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Artificial extracellular matrix proteins were

synthesized using recombinant DNA technology.

These

proteins were meant to mimic the internal elastic lamina of
the tunica intima of muscular arteries for use in the design
of small diameter (<6 mm) vascular prostheses.

These

proteins are composed of two blocks, an elastin-like block
made up of repeats of the pentapeptide (VPGIG) and a cell

binding segment which is composed of the CSS region of
fibronectin.

Proteins of the following sequence were

designed, synthesized and characterized:
(CSS (VPGIG)

20) 5*

(CS5 (VPGIG)

40)

3

and

Successful synthesis and purification were

confirmed by NMR spectroscopy and amino acid analysis.
These artificial extracellular matrix proteins were

designed with both controlled structural integrity and
endothelial cell binding ability.

The presence of a lower

critical solution temperature (LCST) for both proteins
VI

suggests that the properties of the elastin like blocks were
maintained. The endothelial cell binding ability of the CS5

region of fibronectin was also retained, as demonstrated

through human umbilical vein endothelial cell (HUVEC)
adhesion and spreading on the proteins, as well as through
inhibition of this adhesion through preincubation of the

HUVECs with soluble GREDVDY peptide which is known to
inhibit

a43i

integrin binding to CSS.

HUVECs adhered to (CSS (VPGIG) 20)

5

Equivalent numbers of

and to fibronectin,

although the number of cells well spread on the former was
only approximately 5S% of the number of those well spread on
fibronectin.
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CHAPTER

1

INTRODUCTION

The field of tissue engineering draws upon multiple

disciplines to achieve its goal of the design of new

materials for tissue regeneration.

It is a rapidly

expanding field where knowledge about cell-cell and cell-

material interactions, as well as about cell-protein, cellchemical and cell-mechanical interactions are drawn upon to

design materials that will optimize cell growth and

differentiation and tissue regeneration both in vitro and in
vivo.

Extensive research is being conducted on materials

for growth of new skin, liver, bone, cartilage and arteries,

among other tissues. ^"^

These materials are often scaffolds

that support cells and allow them to attach, proliferate,
differentiate, and secrete their own scaffolding or

extracellular matrix.

Each organ has its own

characteristics important in the successful design of
synthetic materials for cell scaffolding; the composition of
the extracellular matrix differs from tissue to tissue.

While cartilage supports the weight of the body, blood
vessels provide the transport network for nutrients and
waste; in view of these differing functions, it is not

surprising that cartilage is composed of more connective
tissue, a collagen rich matrix, while muscular arteries are

composed of more muscular tissue.

1

Materials for

^

regeneration of any organ must provide the proper signals
for the defined organ.

1.1 Vascular Grafts

Vascular grafts, or artificial blood conduits, are used
to replace damaged or diseased vessels.

New materials for

small diameter vascular grafts are needed.

The current

gold standard for bypass surgery, autologous saphenous vein,
has a 30% failure rate due to stenosis within five years.

Expanded polytetraf luoroethylene (PTFE) and polyethylene

terephthalate (PET) are also available for vascular graft
implantation; however, the patency rate of these materials
is lower than that of saphenous vein^.

Desirable materials

would provide a vessel viable for the life of the patient.
Novel artificial extracellular matrix proteins can

readily be designed and synthesized utilizing recombinant
DNA technology.

These proteins may contain isolated

biological signals or a combination of signals.

More

specifically, cell adhesion domains such as the peptide Arg-

Gly-Asp (ROD) can be designed into the backbone of the
protein.^

It is equally possible to synthesize materials

which contain heparin binding domains, collagen binding
domains, or protease degradation sites.

Mechanical

properties of the protein can also be controlled; one way to
accomplish this is by designing an elastomeric-type protein
endowed with mechanical properties similar to those of
native elastin.''"'

Elastin is an extracellular matrix
2

protein which composes the bulk of elastic fibers;
these
fibers are found, among other places, in the intima
of

muscular arteries. ^°
protein containing

We have synthesized an elastomer ic
(i)

repeats of (VPGIG)

(the single letter

amino acid code is used in this and all subsequent
protein
sequences), and (ii) the CSS domain of fibronectin, an

integrin binding domain containing the REDV sequence.
This protein binds human umbilical vein endothelial cells
(HUVECs)

and is expected to exhibit mechanical properties

similar to those seen in chemically synthesized repetitive

polymers of (VPGVG)

,

a

pentapeptide repeat occurring up to

11 times consecutively in native elastin.^^

In the case of vascular grafts it is likely that an

elastic material will be better than a rigid material, as

arteries are quite elastic.

A material must be sufficiently

viscoelastic to maintain flow during diastole^ and must have
sufficient structural integrity so that the new artery does
not burst during systole.
(-100

/im)

Materials must be porous enough

to allow diffusion of metabolites and migration of

cells (such as smooth muscle cells to form a media)

they must remain mechanically sound.

,

yet

The materials must be

biocompatible if they are to be implanted in the body; a

material that elicits a severe immune response will likely
be rejected while those that elicit an inflammatory response

may be "walled off" by fibrous tissue deposition.

In

addition, these materials must interact favorably with the

cells of the vasculature including endothelial cells, smooth
3

muscle cells and platelets.

Materials should not promote

thrombosis or intimal hyperplasia.
is optimal for its function.

To date, native tissue

This knowledge must be

utilized in the design of new materials.

The ideal

synthetic scaffold will support cell growth and

differentiation as well as maintain mechanical integrity
until the seeded or ingrowing cells secrete their own

extracellular matrix.

Finally, the synthetic material

should degrade, leaving in its stead a native tissue. ^'^
Selecting a suitable material for vascular graft

fabrication is quite complex.

Vascular grafts are

immediately exposed to the blood, allowing for the rapid

deposition of blood-borne proteins.
deposited on the graft surface.

These proteins are

Proteins present in the

bloodstream at the highest concentrations are initially

deposited in the highest concentrations.

Over time

equilibrium prevails; those proteins which adhere most
strongly to the vascular graft material will be present at

higher concentration than seen initially.
The adhesion of blood-borne proteins to foreign

material, in particular

platelet adhesion.

f ibrinogen,

often promotes

This may trigger a cascade of events^^

leading to thrombosis, atherosclerosis and ultimately to

graft failure.

Exposure to the blood stream also invokes an

immune or foreign body response.

This response has been

extensively studied and is found to be dependent on graft
material.

In general, bioresorbable materials^^ elicit a

greater foreign body response (which terminates
after
complete resorption) than nonresorbable materials, but

the

response to the nonresorbable material continues
indefinitely.

One approach to the problem of protein

adhesion is the modification of surfaces to create

nonadhesive interfaces.

The modification of polyethylene

terephthalate (PET) surfaces with polyethylene oxide
(PEO) (which increases both the hydrophilicity and mobility

of the surface by motion of the PEO) has been used to make

surfaces less adhesive to proteins and cells/® hence, less
thrombogenic.

PTFE has been modified by plasma

polymerization of tetraf luoroethylene to PTFE films followed
by adhesion of albumin.

Plasma polymerized PTFE shows an

increased affinity for albumin.

Surfaces pretreated with

albumin are less adhesive toward platelets. Conversely,

plasma polymerized PTFE in the presence of oxygen has been
shown to increase the retention of fibronectin and laminin,

hence increasing the adhesion of HUVECs.^°

Healthy vasculature is lined with a monolayer of
endothelial cells which serves many functions including

creating a naturally nonthrombogenic surface.

It may be

possible to achieve a monolayer of endothelial cells lining
the luminal surface of a vascular graft via the growth of

capillaries through the wall of the implant and the
subsequent migration of endothelial cells to the graft
surface.

The use of highly porous

(60/xm

internodal

distance) ePTFE has been shown to allow capillary ingrowth
5

through the walls of the vessel and migration of capillary
endothelial cells onto the graft to form a continuous layer
of endothelial cells in both primates^^ and canines.

However, in humans the only endothelial cell migration in

currently available vascular grafts occurs from the ends of
the graft and proceeds for only 8-lOmm before stopping,

leaving the center of the graft devoid of endothelial
cells.

Another approach to designing patent vascular grafts is
to preseed the graft with endothelial cells."

This is done

to form a nonthrombogenic surface which appears, on the

macroscopic level, to be similar to the native vessel.
Preseeding of vascular material has not yet been shown to be
an effective method for increasing the patency rate in
humans.

However, preliminary data from the labs of both

Peter Zilla^^ and Stewart Williams (personal communication)

suggest patency rates of autologously preseeded PTFE grafts
are equal to autologous saphenous vein at

implantation

5

years post-

.

An alternative method for seeding of endothelial cells
is the use of short peptide sequences for cell binding.

RGDS and related peptides have been shown to bind a variety
of cell types through integrin receptors on the cell

surface.

Grafting of RGD sequences to PTFE surfaces has

shown an enhancement of endothelial cell binding to the

graft material in vitro both in the absence and in the

presence of flow.^^

Massia et al
6

.

covalently bound both

RGDS and REDV to glycophase glass, glass which has been

treated with (3-glycidoxypropyl) trimethoxysilane followed by
hydrolysis of the oxirane moieties to form diols, and

demonstrated that cells would adhere to the peptide-modif ied
surface of the glass.

They also found that endothelial

cells, but not smooth muscle cells, platelets, or

fibroblasts would adhere to the REDV modified glass
surface.

This demonstrates the ability to adhere

selectively certain cell types to surfaces through these
peptides.

In addition,

it has been shown that cell adhesion

and proliferation are dependent on the density of adhesion

peptides.

^°

The density of the peptides may be used to

control the action of the adherent target cells.

Although

these peptides may be readily grafted to the surface of

existing materials, making these materials more adherent

toward cells, they do not alter the overall properties of
the materials.

Grafting peptides to PTFE and PET does not

improve the mechanical properties of these materials, nor
does it promote degradation.

A material which supports a monolayer of endothelial
cells while inducing them to produce their own matrix,

allows the endothelium to remain in an inactivated state,
and is conducive to the development of an intima and a media

comprises an optimal vascular graft material.

7

1.2 Material Design Through Genetic Engineering

Genetic engineering is a powerful technique that, when

combined with ideas from polymer science, allows the

researcher to design materials with precise molecular
sequences and controlled architecture. We and others have

previously reported the biosynthesis of highly repetitive,
monodisperse, silk-like proteins, including derivatives

containing non-proteinogenic amino acids or elastomeric

domains

^^'^^
.

The successful synthesis of elastin-like

proteins by this method has also been reported. ^'^

In

addition, we have described the successful synthesis of

poly (alanylglycine) in multigram quantities,

and have

subsequently applied the described technique to produce

multigram quantities of a variety of recombinant proteins in
our laboratory.

The ability to synthesize multigram

quantities of protein is critical for vascular graft design,
as reasonable quantities of material must be readily

available for mechanical testing and processing of

prosthetic devices.
Due to the ability to control precisely the amino acid

sequence of recombinant proteins, we felt it would be

possible to design an elastomeric protein containing
integrin binding domains that would bind endothelial cells

while remaining nonadhesive toward smooth muscle cells,
platelets and fibroblasts.^^

In addition to controlling the

sequence of the domains, we are able to dictate the density
of the domains, which has been shown to be important in cell
8

.

adhesion, spreading, focal adhesion contact formation/^ and

cell motility/^

This elastin-like protein could be used as

the innermost tunica of a vascular graft.

Since this

material is protein, it is thought that it will eventually
be degraded by the body through natural processes which will

result in nontoxic units that can be utilized by the body or
cleared from the body through normal channels.
In the work reported herein, recombinant proteins were

designed based on the pentapeptide repeat (VPGIG) which is
known to form a beta turn structure and to have mechanical
properties similar to those of native elastin. ^^'''^

Periodically interspersed with the pentapeptide repeat is
the CSS region of fibronectin, which has been shown to bind
to the

integrin receptor

a43i

a receptor

,

which is found

on HUVECs but has not been found on smooth muscle cells,

platelets or

Scheme

f ibroblasts.^^'^^''^^

1

shows the sequence

of the CS5 region plus amino acids resulting from the

linking of the segments at the DNA level.
Scheme

1

CS5 = (LDGEEIQIGHIPREDVDYHLYPGVP)

OVP = insertion site for (VPGIG)
LD = amino acids resulting from DNA linking
The cimino acid sequences of the complete proteins are:
MG(CS5(VPGIG) JyLE

Where X, Y = 20,

5

or 40,

3

The entire CSS region of fibronectin was incorporated into

the protein because it was expected that conformation of the
9

REDV peptide was important for HUVEC binding.

Hubbell et

al. demonstrated that GREDVY peptide coupled to a surface

through the amino terminus was recognized by HUVECs as an
adhesion site, while the same peptide coupled through the
carboxyl terminus did not appear to be recognized by the

HUVECs as it did not promote adhesion/^

confirmed by Nicol et al

.

This was further

when short forms of the REDV

peptide were incorporated, through chemical synthesis, into
repeats of (VPGVG)^ and no HUVEC binding was observed
however, incorporation of short RGD peptides into proteins

composed of (VPGVG) repeats does promote endothelial cell
binding, indicating that the elastin backbone is compatible

with cellular adhesion/^

\

The recombinant proteins,
(CSS (VPGIG)

20) 5;

(CSS (VPGIG)

40)

3

and

serve two functions: the CSS region provides

the signals for cell adhesion while the (VPGIG) repeat

provides the desired mechanical properties.

The

construction of the proteins was based on two DNA monomers
that encode the CSS region or the (VPGIG) repeats,
respectively.

These monomers were interconnected through

cohesive ends to build the genes of interest, which were

cloned into an Escherichia coli expression host.

1.3 Tissue and Organ Complexity

These novel extracellular matrix proteins are meant to
serve as the internal elastic lamina of an artery.

However,

as with other organs, the arteries are composed of more than
10

one tissue.

In most tissue engineering applications,

it is

likely that more than one material will be necessary to

rebuild the tissue of interest.

Different materials elicit

different responses from cells.

Chondrocytes cultured on

type

1

collagen secrete large amounts of collagen, while the

same chondrocytes cultured on polyglycolic acid secrete
large quantities of proteoglycans.''^

Several signals may be

necessary to create the optimal environment for tissue
regeneration, while more than one material may be necessary
to achieve the desired mechanical properties or even the

desired structure.
Arteries are made up of three layers or tunicas.

The

composition of each tunica is different, both in dominant
cell type and in extracellular matrix composition. The three
tunicas, as seen from the lumin outward, are the tunica
intima, the tunica media, and the tunica adventitia.

The

muscular arteries are the vessels of interest for vascular
graft design, for it is these arteries that fail.^

The

tunica intima of muscular arteries is lined with a monolayer
of endothelial cells which lie on a basal lamina.

Immediately juxtaposed to the endothelium is an internal

elastic membrane.

Elastic, artificial extracellular

matrix proteins such as those based on the (VPGIG) repeat
may be able to mimic this tunica.

The tunica media of these

arteries consists largely of smooth muscle cells surrounded
by collagen.

An artificial collagen which binds smooth

muscle cells may be able to mimic the tunica media.

The

adventitia consists of both elastic and collagen fibrils and
fibroblasts.^^

It will be possible to blend the elastin

like proteins with collagen analogues to mimic both the

tunica media and the adventitia.

Multilayered vascular

grafts can then be fabricated to produce vascular
prostheses.

1.4 High Cell Density Fermentation

In order to fabricate grafts it is necessary to produce

the graft materials in large quantities.

We have found

through batch fermentation that it is possible to produce
10-100 mg/1 of recombinant protein.

Considering the best

case where 100 mg/1 of protein was produced, a 10

fermentation is necessary to produce
protein.

1 g of

1

recombinant

This is not time or cost effective.

Through a fed

batch fermentation process which is a modification of the

process by Riesenburg et al.^° we have been able to improve

protein yields so that we can recover approximately

1

g/1 of

recombinant protein.

1.5 Dissertation Plan

Chapter

2

describes the high cell density fermentation

procedure as well as the design, synthesis and
characterization of poly (alanylglycine)

.

Batch and fed

batch fermentations are compared and the recombinant protein
is evaluated by NMR spectroscopy, elemental analysis and

12

amino acid analysis, as well as Fourier transform infrared

spectroscopy and x-ray diffraction.
The recombinant artificial extracellular matrix

proteins are introduced in chapter

3.

They are evaluated by

amino acid analysis and NMR spectroscopy.

The ability of

HUVECs to adhere to the proteins and the number of cells

attached to protein surfaces are also discussed.
The morphology of HUVECs on the protein surfaces and on

glass is evaluated in chapter

4.

LCST data of the proteins

is presented as well as the stability of films of the

proteins in aqueous solutions above the LCST.
The appendices contain more detailed information on DNA

manipulations and on protein characterization.
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CHAPTER

Poly (L-ALANYLGLYCINE)

:

2

MULT I GRAM- SCALE BIOSYNTHESIS,

CRYSTALLIZATION, AND STRUCTURAL ANALYSIS

2

.

1

Abstract
The biosynthesis of poly (L-alanylglycine)

(poly (AG))

was performed in high cell density cultures of recombinant

Escherichia coli

.

The purity of the material was determined

by amino acid analysis, elemental analysis and

spectroscopy.

NMR

^H

Fed batch fermentation increased the yield of

recombinant protein from levels of tens of milligrams per
liter (typical of batch fermentation in rich media) to

hundreds of milligrams per liter.

Poly (AG) was

recrystallized from dichloroacetic acid solutions in the
form of texture-oriented chain-folded lamellae with a

lamellar stacking periodicity of 3.2 nm.

The crystal

structure within the lamellar core is similar in general,
but different in detail, to the antiparallel 3-sheet

structure previously reported for oriented films of poly (AG)
and fibers of Bombyx mori silk fibroin (silk II)

structure consists of polar antiparallel

(ap)

.

The

p-sheets, with

repetitive folding through y-turns every eighth amino acid
(including the fold), stacking with like surfaces together.

The wide angle x-ray diffraction signals index on an

orthorhombic unit cell with a (hydrogen bond direction) =
0.948 nm,

Jb

(sheet stacking direction) = 0.922 nm, and c

The stacking distance (b-

(chain direction) = 0.695 nm.
14

.

value)

,

is increased by about 4% in comparison with the

previously reported structure of poly (AG)

,

owing, we

believe, to steric interaction at the lamellar fold

surfaces.

Random shears of approximately

± a/ 4

and

alternating shears of +c/2 and -c/2 in the ac plane are
required to obtain a good fit between the calculated and

measured x-ray structure factors.

2

.

2

Introduction

Recombinant DNA technology is a powerful tool for
synthesis of novel proteins for pharmaceutical and

biomedical applications^^'

as well as for research in

structural biology and protein folding.

previously

reported^^'"'^^'^" the

We and others have

biosynthesis of highly

repetitive, monodisperse, silk-like proteins, including

derivatives containing non-proteinogenic amino acids^^ or
elastomer ic domains. ^^'^^ We describe herein the preparation,
on a multigram scale, of two monodisperse variants of the
"parent" polymer in this family of materials, poly(L-

alanylglycine)

(poly(AG)).

These polymers can be

crystallized to form silk Il-like p-sheet structures, as
shown by Fourier transform infrared spectroscopy (FTIR)
small angle x-ray scattering (SAXS) and wide angle x-ray

scattering (WAXS)
Poly (AG)

(as prepared by chemical synthesis)

studied previously

"'^^
.

has been

Eraser et al. prepared poly (AG) by

polymerization of an L-alanylglycine p-nitrophenyl ester
15

monomer, resulting in a degree of polymerization of
about

40."

Lotz and Keith used the pentachlorophenyl ester as

monomer and obtained molecular weights in the range of
15,000 to 20,000."

Infrared and x-ray scattering data

indicated that such polymers form either the silk

I

(crankshaft geometry) or the silk II (3-sheet geometry)

structures depending on sample preparation conditions."
We have reported previously the use of genetic

engineering to produce artificial proteins that adopt
predictable, chain-folded antiparallel (ap) p-sheet

structures in the solid state. ^^'"'^^

The chain-folded

lamellar architecture^^'" is a kinetic trap in the

crystallization of all linear polymers sufficiently flexible
to form hairpin-like folds, and it is known that protein

chains in the 3-conf ormation can make tight turns, with
either one or two amide groups (two or three amino acid
atoms)

in the fold.

Cq,-

The egg-stalk silk protein of the

green-wing fly Chrysopa flava folds with

a

periodicity

corresponding to eight amino acids to form lamellae of
thickness

«

3

nm,^^ and

nylons 4" and

4,6*^^

crystallize with

amide units, rather than polymethylene segments, in the
turn.

The biosynthesis of multigram quantities of poly (AG)

with known chain lengths well in excess of the expected fold

periodicity allowed us to search for chain-folding in
poly (AG), and to compare the folded-chain structure with
that previously reported by Eraser et

16

al.^^'^^

The yield of a recombinant protein in bacterial

fermentations is determined in part by the total number of
cells in the culture.

Traditional batch reactors yield

approximately 1.5 g dry cell weight per liter.

This low

ratio of biomass to culture volume leads to low efficiency
in terms of space, time, and cost.

Alternatively, fed batch

processes yield significantly greater cell densities; values
up to approximately 100 g dry cell weight per liter have

been reported.
We describe in this chapter simple fed batch techniques

with the addition of oxygen that have increased the yield of
poly (AG) from tens of milligrams per liter (using batch
techniques) to hundreds of milligrams per liter.

We also

discuss the structural analysis of poly (AG) by infrared and
x-ray diffraction methods.

2

.

3

Experimental Section

2.3.1 Materials
T4 DNA liqase, T4 polynucleotide kinase, calf

intestinal phosphatase, and all restriction enzymes were

purchased from New Enqland Biolabs.
Deoxyribonuclease

I,

Ribonuclease A,

Orqanic Antifoam, Ampicillin and

chloramphenicol were purchased from Sigma Chemical Co.

Escherichia coli strains DH5aF* and HBlOl were purchased
from Bethesda Research Laboratories.

Plasmid p937.51 was a

gift of Protein Polymer Technologies, Inc.
17

The expression

plasmid pET-3b and E. coli strain BL21 (DE3)pLyss'^^
obtained from Novagen.

2.3.2 General Methods

Bacterial growth in rich medium, DNA manipulations and

transformation conditions were performed as described in
Sambrook, Frisch and Maniatis.^^ Fourier transform infrared

spectra were obtained from KBr pellets on a Perkin Elmer
1600 series FTIR spectrophotometer.

on a Bruker AMX 500 MHZ spectrometer.

NMR spectra were run

Ultraviolet spectra

were obtained in distilled water on a Hitachi U2000
spectrophotometer in quartz cuvettes with a path length of

1

cm, while cell density measurements were done in plastic

cuvettes at X=600 nm.

High cell density medium for

fermentations was adapted from Riesenberg et al.^° with the

addition of 100%
reached.

O2

once an optical density

(ODgoo)

of 10 was

A New Brunswick SOL mobile pilot plant (MPP-80)

was used for high cell density fermentation.

Centrifugation was performed using a Cepa Z41 continuous
centrifuge. Amino acid analyses were obtained from an

Applied Biosystems 420/130A derivatizer-analyzer following
hydrolysis and derivatization with phenylisothiocyanate;
data were analyzed with the Applied Biosystems 920A data
module.

18

2.3.3 Preparation of Synthetic DNA

Oligonucleotides

were synthesized on a

(1)

1

scale

^i^nol

on a Biosearch Model 8700 DNA synthesizer using

phosphoramidite chemistry

.

Crude oligonucleotides were

purified by denaturing polyacrylamide gel electrophoresis
and eluted using the "crush and soak"

method.^''

oligonucleotides were annealed at 80

°C and

to room temperature over several hours.
(1)

Purified

allowed to cool

The annealed duplex

was phosphorylated with T4 polynucleotide kinase,

ethanol precipitated and dried in vacuo.

stop Gly Ala Gly Ala Gly Ala Gly Ala Gly
AAT TOG TAA GGT GCC GGT GCG GGT GCA GGT GCG GGT GCC GGC
ATT CCA CGG CCA CGC CCA GGT CCA CGC CCA CGG CCG AG

II

Eco RI

2

Ban

II

Ban

I

(1)

Bam HI

I

•3.4 Cloning and Amplification of Synthetic DNA

The purified synthetic duplex was ligated into Eco

RI/Bam HI digested pUC18^^ and used to transform E. coli
strain DH5aF'.

Cells were grown at 37 °C overnight on 2xYT

solid medium containing 200

/ig/ml ampicillin,

isopropylthiogalactoside (IPTG) and 40

25

/xg/ml of

jitg/ml

3-

the

chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-Dgalactopyranoside (X-Gal) for blue-white screening.

Plasmid

DNA from white transf ormants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the

insert.

After isolation of the recombinant plasmid from a

1

liter 2XYT culture, the DNA was digested with Ban

and the

I

fragments were separated by nondenaturing polyacrylamide gel
electrophoresis.

The DNA monomer was eluted from the

polyacrylamide slice using the "crush and soak" method."

2.3.5 Polymerization of the DNA Monomer and Cloning of DNA

Multimers
Purified monomeric DNA was self-ligated with T4 DNA
ligase to form a population of multimers.

Multimers were

resolved by electrophoresis and ligated into Ban

digested,

I

dephosphorylated p937.51, a small, high copy number cloning

vector that carries an origin of replication from pBR322 and
a gene encoding chloramphenicol acetyltransf erase

.

^°

The

recombinant plasmids were used to transform E. coli strain
HBIOI.

Transf ormants were screened by restriction enzyme

digest analysis and clones encoding 16 and 60 repeats of the

monomer were selected.
designated p937 51- (AG)
.

The recombinant plasmids were
e-,

or p937 51- (AG)
.

240

respectively.

2.3.6 Construction of Bacterial Expression Vector

Recombinant p937 51- (AG)

or

.

p937 51- (AG) ^ was
.

digested with Bam HI to release the multimer.

The fragments

were separated by 1% low melting point agarose gel

electrophoresis and recovered by extraction with phenol and

with phenol/chloroform, and finally by ethanol
precipitation.

The recovered DNA was ligated into Bam HI

digested, dephosphorylated

pET-3b and used to transform
20

.

.

E.

coli strain HBlOl.

Transf ormants were screened for the

presence and orientation of each multimer by Ava
digestion.

I

Recombinant plasmids, designated pET3b- (AG)

and pET3b-(AG)64 respectively, containing inserts in the

correct orientation were used to transform the expression
host, E. coli strain BL21 (DE3 ) pLysS

2.3.7 Protein Expression, Batch Phase, Rich Medium

Single colonies of BL21 (DE3) pLysS containing

recombinant pET3b- (AG) 240 or pET3b-(AG)e4 were used to
inoculate

ml of LB medium containing chloramphenicol (34

5

Hq/ml) and ampicillin (200 /xg/ml)

The cultures were grown

.

to saturation and used to inoculate

medium containing chloramphenicol
(2 00 /Lig/ml)

.

7

50 ml volumes of LB

(34 jug/ml)

The cultures were grown to

and ampicillin

ODgoo =

1

at 37

C

and protein expression was induced by the addition of IPTG
to a final concentration of

after

2

Cells were harvested

0.4 mM.

hours by centrif ugation (2,520 x

g,

15 min at 4 °C)

The cell pellets were resuspended in 10 mL of water and

stored at -20

"C.

2.3.8 Protein Purification

Frozen cells were thawed and phenylmethyl sulfonyl

fluoride (PMSF)

DNAse (20

^iq/ml)

at 37 °C for

30

(1 mM)

,

MgCl2 (5 mM)

were added.

,

RNAse (20 nq/ml) and

The solutions were incubated

min and the insoluble portion was recovered

by centrifugation (10,000 x g,

4 °C,

15 min).

The pellets

were resuspended in 10 ml TENT solution (50 mM Tris-Cl
(pH
10 mM EDTA,

8.0),

100 mM NaCl,

0.5-0.7% Triton X-100) and

incubated with shaking at room temperature for

30

min.

The

insoluble portion was recovered by centrif ugation
(10,000 X g,

4

for 15 minutes.

C)

The pellets were

resuspended in 10 ml of TENS (50 mM Tris-Cl (pH 8.0), 10 mM
100 mM NaCl, 0.5% sodium dodecylsulf ate (SDS)

EDTA,

)

and

incubated at room temperature with shaking for 60 min.

The

insoluble portion was recovered by centrif ugation
(10,000 X g,

repeated.

4

"C,

15 min)

and the TENS treatment was

The resulting pellet was resuspended in TEN plus

porcine pancreatic lipase (20
for

30

minutes.

fig/mh)

and incubated at 37

"C

The insoluble portion was recovered by

centrif ugation (10,000 x

g,

4

C,

The pellet was

15 min).

then washed sequentially with 10 mL TENT, 10 mL water, 10 mL
chloroform: methanol acetone 40:30:30, 10 mL of acetone,
:

10 mL water and 10 mL water.

The insoluble portion was

recovered by centrifugation (10,000 x
each wash.

g,

4

°C,

15 min)

after

The recovered fusion protein was then dried and

weighed.

2.3.9 Cleavage of Fusion Protein

Cyanogen bromide cleavage of the fusion proteins was

accomplished by the method of Smith.

''^

Approximately 35 mg

of fusion protein was dissolved in 5.5 mL of 98% formic acid

and diluted to 70% formic acid with distilled water.

The

solution was deoxygenated with nitrogen and 50 mg of CNBr
22

crystals was added.

The solution was stirred at room

temperature for 24 hr and the solvent was removed by rotary
evaporation.

The residue was washed with distilled water

several times and the insoluble portion was recovered by

centrifugation and dried by lyophilization.

2.3.10 High Cell Density Fermentation and Protein Expression

A

5

ml volume of 2xYT medium containing chloramphenicol

and ampicillin (200 /xg/ml) was inoculated with a

(34 Mg/ml)

single colony of BL21 (DE3) pLysS pET-3b(AG) 240-

The culture

was incubated in a rotary shaker at 37°C until visible

turbidity was reached (approximately

6 hrs)

and then used

,

to inoculate 100 mL of 2xYT medium containing

chloramphenicol (34

/xg/ml)

and ampicillin (200 /ig/ml)

was grown to visual turbidity at 37

inoculate
(34 /Ltg/ml)

°C,

.

This

and then used to

liters of 2xYT medium containing chloramphenicol

2

and ampicillin (200

/itg/ml)

.

The culture was

grown to saturation overnight and the cells were harvested
by centrifugation at 4,000 rpm for 10 min.

The resulting

pellet was used to inoculate 35 liters of the minimal
medium^° specified in Table 2.1. ampicillin and

chloramphenicol were added to final concentrations of 200
/Lig/mL

and 34

respectively.

/Ltg/mL

Ammonium hydroxide (25%)

was used as the base (which was fed through the base pump of
the pH controller)

,

both to control pH and to provide a

nitrogen source. The culture was grown in an 80 liter New
Brunswick fermentor until the glucose was depleted as

determined by a rise in pH above the set point, pH 6,8.

At

this time a glucose feed (50% w/v glucose/water) was

established.

Glucose was fed through the acid pump of the

pH controller; pH was maintained at 6.8.^^

Pure

O2

was used

to ensure aerobic conditions when air was insufficient to

maintain the dissolved oxygen concentration above 20%.
Induction was achieved by the addition of 1.0 mM IPTG when
the

ODeoo

reached 25-30.

Cultures were grown for

4

hr prior

to harvesting by centrif ugation with a Cepa Z41 continuous

centrifuge.

Cells were weighed and resuspended in

water per gram of cells (wet weight)

.

4

mL of

Protein purification

was performed as described above.

2.3.11 Infrared Spectroscopy

Poly (AG) comprising 64 dyads ((AG) 64) was prepared for

crystallization by dissolving 30 mg of protein in
98% formic acid.

1

itiL

of

The solution was diluted to 70% formic

acid by addition of distilled water, and stirred until a gel
formed (about 10 hr)

.

The gel was washed with methanol,

dried and crushed to form a KBr pellet for infrared
analysis.

2.3.12 X-ray Diffraction

Poly (AG), in the form of a white powder, was

continuously added to a mixture of dichloroacetic acid and
10% aqueous lithium hydroxide at 60°C and stirred until a

gel formed.

The gel was compressed between two filters at

50°C until dry (approximately

4

h)

X-ray diffraction

.

photographs from these compressed crystalline mats were

obtained using a Statton-type x-ray camera, evacuated to
backing pump pressure to reduce air scatter.

The nickel-

filtered CuKa sealed beam source was collimated with a

system of 200

/xm

pinholes.

The diffraction photographs were

recorded on x-ray film with specimen-to-film distances of
50-100 mm.

X-ray diffraction photographs of the mats were

obtained with the x-ray beam directed either parallel or

perpendicular to the surface of the mat.

2.3.13 Computer Modeling and Simulated X-ray Diffraction

Patterns

Molecular modeling was performed on a Silicon Graphics
Iris 4D20 workstation using the following software packages:

Discover 2.9 (Biosym Technologies) and Cerius
(Molecular Simulations, Inc.).

2,

Release 1.6

The simulated x-ray

diffraction patterns were created on

a Silicon

Indigo R4000 using the Diffraction

module of the Cerius

Release 1.6, program.

1

Graphics

The appropriate Lorentz and

polarization correction factors are incorporated in the
displayed intensities.

The degree of arcing and the

temperature factor were chosen to match the observed x-ray

diffraction photographs.
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2.4 Results and Discussion

2.4.1 Gene Construction

The strategy used in our laboratory to prepare

artificial proteins has been described previously

.

In

this work, DNAs encoding two chain-length variants of

poly (AG) were ligated into the Bam HI site of the expression

plasmid pET-3b.

The resulting recombinant plasmids encode

either 16 or 60 repeats of the alanylglycine tetramer,
flanked by N- and C- terminal extensions of 23 and 33 amino
acids respectively
from

(2)

.

These terminal regions are derived

the transfer and expression vectors and can be removed

by CNBr cleavage at flanking methionine residues.

MASMTGGQQMGRDPMFKYSRDPM G-[(AG)4]n
^^RMHIRPGAYQLDPAANKARKEAGLAAATAEQ
n= 16or60
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2.4.2 Protein Expression

The host used for protein expression was E. coli strain

BL21(DE3)pLysS."

In this strain, a gene encoding T7 RNA

polymerase is incorporated into the bacterial chromosome
under lacUVS control, and protein production is induced by
the addition of IPTG.

The pLysS plasmid provides low levels

of T7 lysozyme, which inhibits T7 RNA polymerase and

suppresses the basal level of protein expression.
Protein expression in rich medium was performed as

described in the Experimental Section.

Aliquots of cultures

representing approximately equal numbers of cells (as

determined by the optical density at 600 nm) were removed

periodically after induction of protein synthesis (t=
60,

120,

180 min)

.

0,

30,

Samples were loaded onto a 12.5%

polyacrylamide gel and separated by electrophoresis.
Protein bands were stained with Coomassie Brilliant Blue R250.

The recombinant protein was insoluble in SDS and did

not migrate during SDS-PAGE; however, increased stain

intensity following induction could be seen in the wells of
the stacking gel (data not shown) indicating inducible

protein production.
Protein production in minimal medium was carried out in
a New Brunswick SOL Mobile pilot plant as described above.

The growth medium (Table 2.1) was adapted from that reported
by Riesenburg et al.^° Oxygenation of the culture must be

maintained in order to insure aerobic growth during the
induction period; otherwise no recombinant protein is
27

produced.

Oxygen was bubbled through the medium at a flow

rate which maintained the dissolved oxygen content

approximately 20% above the

medium was deoxygenated with
batch phase growth

(ODgoo

O2

level obtained when the

N2.

After the termination of

= 21) a 50%

(w/v)

was fed on demand through the pH pump.

glucose solution

Upon depletion of

glucose as the carbon source, the culture begins to

metabolize acetic acid previously produced as a result of
glucose metabolism.

Depletion of acetic acid results in an

increase in pH; the acid pump is turned on and glucose is
fed to the culture.

lowers the pH.

Acetic acid is then produced, and again

This allows both the carbon source

(glucose) and the nitrogen source (ammonium hydroxide) to be

fed on demand through the pH control mechanism of the
system.

The addition of glucose by pH control is similar to

the method used by Frude et al.,^^ except that in the

present work the base source is also the nitrogen source.

2.4.3 Protein Purification and Analysis

Table 2.2 shows the weight of recombinant protein

produced per gram wet cell weight for cultures of
BL21(DE3)pLysS pET-3b- (AG) 240 grown to optical densities (600
nm)

of 1,

10,

or 25 prior to protein induction with IPTG.

An optical density of 25 corresponds to approximately 10
cell doublings of the inoculum.

There is no loss of protein

produced per gram of wet cell weight (WCW) as the cell
density is increased from 3-4 g WCW/L to 64 g WCW/L prior to
28

.

protein induction.

This result indicates that we are not at

the limit of the method, and suggests that these cultures

might be grown to still higher densities with further
increase in the amount of recombinant protein produced per
liter of culture.

Amino acid analyses for both
in Table 2.3.

(AG)

54

and (AG) 240 are shown

The (AG) 240 Product was found to contain

approximately 5% valine. Two-dimensional NOSY NMR spectra of
the recombinant protein confirmed the presence of valine in
the polymer (Appendix

F)

,

suggesting mutation of the coding

sequence subsequent to sequencing of the DNA monomer.

Conversion of alanine to valine was observed previously in
our work on the related polypeptide

(

(AG) 4PEG)

14

.^^

The

shorter recombinant molecule does not appear to contain
these changes to valine as determined by amino acid analysis
(Table 2.3)

The
2.1)

NMR spectrum of (AG)

64

in formic acid (Figure

shows the alanine a-proton multiplet at 4.4 5 ppm and

the CH3 doublet at 1.36 ppm. The glycine a-CH2 signal occurs
at 4.05 ppm.

The absence of other signals indicates sample

purity, consistent with the results of amino acid analysis

reported in Table 2.3.
The results of elemental analysis are shown in Table
2.4, and are compared with the theoretical analysis for the

product containing 3% water.

Addition of 3% water gives

good agreement with the experimental results for carbon and

hydrogen content; we find nitrogen analysis consistently
29

lower than theoretical predictions for these kinds of

artificial proteins. ^^'^^

2.4.4 Solid State Properties

Crystalline samples of (AG)

64

were prepared as

described in the Experimental Section.

The infrared

spectrum of the crystalline polymer, shown in Figure 2.2,
exhibits amide

I

and amide II vibrational modes at 1629 and

1529 cm"^ respectively, characteristic of the 3-sheet

conformation.
The wide angle x-ray diffraction photograph, taken with
the x-ray beam directed parallel to the plane of the

compressed mat and with the mat normal horizontal, is shown
in Figure 2.3a.

The diffraction photograph exhibits

discrete Bragg diffraction signals consistent with an
oriented crystalline polymer, and all observed signals index
on an orthorhombic unit cell with dimensions a = 0.948 nm,

The measured and calculated

b = 0.922 nm and c = 0.695 nm.

inter-planar spacings are listed for comparison in Table 2.5

together with an estimate of the observed intensities.

In

addition a set of low angle equatorial diffraction arcs,
orders of 3.2 nm, were seen.

This set of diffraction

signals is noticeably different in character from the wideangle diffraction signals; the degree of arcing is less by
about a factor of two and they vary in intensity relative to
the wide angle signals in different samples; indeed, in some

cases they are so weak that they are barely detectable,
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except for a diffuse first order at

a

spacing «3.6 nm.

Their appearance or non-appearance did not change the nature
of spacings of the other diffraction signals.

The orientation direction is along

a.

Thus the

directionally coincident a and a* axes lie along the

meridian line (vertical bisector)

,

and therefore, the hOO

diffraction signals, the easily seen 200 and 400 in
particular, appear as arcs centered on that meridian.

The

families of OkO and 001 diffraction signals appear on the

equator (horizontal bisector)

.

This type of texture-

oriented x-ray diffraction pattern is similar to that

reported previously for

poly (AG)

jEG.

^^'^^

Differences in the line broadening of the various

diffraction signals, which relate in a consistent way to
their assigned Miller indices, are observed in Figure 2.3a.
The 200 and 400 diffraction arcs are particularly sharp, and

demand long range correlational order along the a-axis.

Diffraction signals with indices of the general hkl type are

considerably broader than those with indices hkO; this
comparison leads us to the conclusion that the coherent
scattering length in the c direction is small.
a length of

2

to

4

We estimate

nm (allowing for instrumental line

broadening); this is ca. 16 times less than the length of
the protein chain.

The coherent scattering length in the b

direction is intermediate between those in the a and c
directions.
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The wide-angle x-ray photograph taken with the x-ray

beam directed orthogonal to the compressed mat is shown in
Figure 2.3b.

The diffraction signals appear as a set of

concentric rings, which index on the orthorhombic lattice

deduced from analysis of the oriented pattern.
The texture-oriented wide-angle x-ray diffraction

photograph shown in Figure 2.3a, obtained with the x-ray
beam parallel to the surface of the mat, is similar to that

previously reported for oriented films of poly (AG) by Fraser
et al.;^^'^^ however, that paper contained no report of any

x-ray diffraction photographs taken with the x-ray beam
orthogonal to the films.

The films were stroked during

drying and it was implied that the a-axis is a unique

direction

as a consequence, their structure analysis

assumed cylindrical averaging (fiber symmetry) about the aaxis.

In our samples, prepared by compression into mats,

the a-axis is merely confined to the plane of the mat, with

random rotation about the mat normal.

It is vital to

recognize there is a texture and to establish its nature if
the x-ray structure analysis is to be performed correctly.
The overall features of our x-ray diffraction pattern are

sufficiently similar to those of Fraser et al."'^^ that we
are confident that we have the same basic crystalline

structure, even if our texture is different.

Fraser et al.,"'^^ proposed the following model.

The

structure consists of polar apP-sheets, stacked in pairs

with alanyl faces together and glycyl surfaces together.

respectively.

The stacking direction is parallel to the b

axis; the unequal packing of the ap3-sheets is responsible

for the appearance of the 010 diffraction signal.

Successive sheets shear ±a/4 parallel to the a axis
(hydrogen bond direction) in the ac plane.

parallel to the chain axis.

The c axis is

The only difference between our

unit cell and that reported by Fraser et al."'^^ is the value
of b, the sheet stacking parameter; their reported value of

0.887 nm is 3.8% less than our 0.922 nm-value.

A

perspective view of the structure and the unit cell is shown
in Figure 2.4 and a simulated x-ray diffraction pattern
(SXDP)

of this structure generated for comparison with the

observed x-ray data is shown in Figure 2.3c.

Comparison of

Figures 2.3a and 2.3c shows that although the match between
the observed and calculated diffraction patterns is

reasonably good overall, there are noticeable discrepancies,
the most obvious of which is the unwanted Ikl diffraction

signals on the first layer line.

Unwanted first layer line

diffraction occurs even if fiber symmetry is assumed
(although, of course, the relative intensities will be

different)

.

It can be removed by random shears of ±a/4 in

the ac plane; thus, the model proposed by Fraser et al."'^^
is not correct in detail.

In addition there are other

discrepancies between the calculated and experimental x-ray

diffraction patterns; there are unwanted Okl equatorial
diffraction signals in the region between the 010 and 020
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and there is poor agreement with the observed hOO
intensities.

The low-angle equatorial diffraction pattern (which

consists of orders of 3.2 nm)

,

and the relative broadening

of selected wide-angle diffraction signals favor a chain-

folded lamellar structure for the poly (AG) crystals prepared
in this work.

Our interpretation of the poly (AG) x-ray

diffraction results has benefited from the detailed analysis
of poly (AG) 3EG.^^

The appearance of the first few orders of

the 3.2 nm on the equator indicate that the lamellae are

stacking reasonably well at the stacking periodicity of
3.2 nm.

In a number of crystal preparations only a diffuse

first order at spacing 3.6 nm (12% greater) was observed.

This is consistent with poorly stacked lamellae.

Figure 2.5

shows an orthogonal view (parallel to Jb-axis) of a chain-

folded ap(3-sheet that is consistent with the x-ray data.
The Y~"turns are necessary to generate the polar apPsheets.^^

Y-turn.

Alanine residues are placed at the apex of each
There are two possible sequences for the y-turns,

either GAG or AGA.

Since we knew a priori that the

resolution of the experimental data would not allow us to
delineate the fine details of the fold geometry we chose the
GAG Y-turn as the basis of our model.

It should be noted

that the folds on the right-hand edge of the sheet are

conformational ly different from those on the left.

A more

detailed perspective view of one of the y-turns is shown in
Figure 2.6.

The sheets are stacked by making a rotation,

n,

about the a-axis; thus, in the chain-folded lamellar
crystal

both surfaces are equally populated with the two types of
fold conformation.

With regard to the stacking of the polar

ap3-sheets, there are two possibilities if like surfaces are
to be in contact, either a rotation, n, about the a-axis, or
a rotation, n,

about the c-axis.

The former structure was

favored since it results in a chain folded lamellar crystal

with both surfaces equally populated with the two types of
fold conformations.

Various structures for poly (AG) were generated by

computer and the stereochemical feasibility of each was
examined using modeling procedures.

SXDPs were generated

for comparison with the observed x-ray data.

We discovered

that all structures that incorporate regular inter-sheet

shears of ±a/4 parallel to the a axis generate unwanted

intensity for the Ikl diffraction signals.
in the SXPD shown in Figure 2.3c,

This can be seen

The only way to remove

this intensity is by incorporating random ±a/4 shears in the

ac plane.

In addition there are unwanted diffraction

signals on the equator which are removed by alternating +c/2
and

We have also found this

-c/2 shears in the ac plane.

effect in the structure of poly (AG)

3

EG.

A still better

fit can be found if the random shears are only~±a/4.

The

closest overall fit with the observed x-ray data is
illustrated in Figure 2.3d, and the final structure is shown
in Figure 2.7.
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Fraser et

al."^'"'

did not raise the issue of chain-

folding in the app-sheets of poly (AG),

in our recent

studies of related periodic polypeptides''''' crystallized in

very similar circumstances, we have found that the chains
fold regularly through y-turns to form crystalline lamellae

approximately 3-4 nm thick.

Chain folding, of course, is an

obvious geometric contender in structures involving

antiparallel chains.

We suspect that our slightly increased

value for the average inter-sheet stacking parameter b/2 is
a result of steric interactions at fold surfaces.

It was

noticed that the jb-value decreased as the fold period
increased in the series poly (AG) xEG^' as the integer x

changed successively from

with our suggestion.

3

to

6,

which would be consistent

Further support was found in the

systematic study of the series: poly(AG)3XG, where X varied
from serine to tyrosine; a linear relationship between

increasing volume and increasing Jb-value was established.^"

Given the low degree of polymerization of the poly (AG) used
by Fraser et

ai.;^^'^^

folding occurred.

it may be that little,

if any,

chain

No low-angle diffraction features were

reported.

2.5 Conclusions

Poly (AG) has been prepared by biological synthesis in

multigram quantities; 25 g of the recombinant fusion protein
was recovered from 35 liters of culture.

This required only

a simple fed-batch fermentation without elaborate feedback
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controls.

The observation that there is no decrease in

recombinant protein production with increased cell density
suggests that limiting yields have not yet been reached.

Little or no loss in recombinant protein production with
increased cell doubling also indicates good plasmid

stability in the host strain.
The x-ray diffraction results show that poly (AG) can

crystallize in the form of chain-folded lamellae

approximately 3.2 nm thick.

The structure consists of polar

app-sheets folding through yturns.

The sheets stack in

pairs with alanyl faces together and glycyl faces together,
respectively, with a stacking periodicity about 4% greater

than that reported previously by Fraser et

chain folding was not evident.

al.,^^'^^

where

To obtain good agreement

between the calculated and observed x-ray structure factors,
successive sheets must shear randomly
+C/2 and -c/2 in the ac plane.

~

±a/4 and alternately

The calculated diffraction

data are presented in the form of look alike patterns which
are a convenient and, we judge, a stringent test for the

proposed structure.
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Table 2.1 Minimal Medium Composition for High Cell
Density Fermentation

component

initial concn.

KH2PO4

13.3 g/L

(NH4)HP04

4.0 g/L

citric acid

1.7 g/L

MgS04-7H20

1.2 g/L

trace metal solution^

10 mL/L

thiamine hydrochloride

4.5 mg/L

glucose. H2O

27.5 g/L

antifoam

0.1 mL/L

feed solution

glucose

500 g/L

NH2OH

25%

^Trace metal solution:
MnCl2-4H20,

NaMo04-2H20,

6

g/L iron (III) citrate, 1.5 g/L

0.8 g/L Zn (CH3COO) 2H2O, 0.3 g/L H3BO3, 0.25 g/L

0.25 g/L CoCl2'6H2)

,
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0.15 g/L CuCL2-2H20.

.

.

Table 2.2 Recombinant Protein

.

((AG),,o Fusion)

Recovered from

Cultures of Three Different Cell Densities

'

ODsoo

wet cell
weight (g/L)

recombinant
protein/wet cell
weight (mg/g)

1^

3

16

lO"

26

20

0.42

5.2

25''

64

15

0.96

25

product
yield (g/L)

0.

total
product
yield (a

048

0. 048

L overall culture volume
35 L overall culture volume
1

Table 2.3 Theoretical and Experimental Amino Acid
Analyses for (AG)

mol

amino acid

theor

%

64

and (AG) 240

mol

(AG)m

exptl

theor.

%

(AG)

,

40

exptl

aspartic acid

0.00

0.62

0. 00

0.00

alanine

49.23

52.59

49.79

49.00

glycine

49.23

46.28

49.79

46. 54

arginine

0.77

0.51

0.21

0.00

homoserine

0.77

0.21

0.00

valine

0.00

0.00

4.45

0. 00
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Table 2.4

Elemental Analyses of

(AG)e4

Including both

Experimental and Theoretical Calculations

element
carbon

theor

theor

46.85

± 3%H20

45.45

exptl.

45.39

hydrogen

6.33

6.48

6.35

nitrogen

21.86

21.20

19.78
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Table 2.5
Spacings

Comparison of Observed Diffraction Signal

(do)

with Those Calculated

(Errors ± 0.002 nm)
(AG)

,

(d^)

,

in Nanometers

for the Orthorhombic Unit Cell of

Together with an Estimate of Observed Intensities
S = sharp,

M = medium, W = weak
(Xo)

(AG)^^:

a = 0.948 nm,

b = 0.922 nm, c = 0.695 nm

hkl

do

010

0

020

0 .461

0

021

0.375

030

0

.

031

0

.

.

0.922

S

.

461

s

0

.

384

M

310

0

.

307

M

282

0.281

M

922

0.277

022

040

0.231

0.231

W

200

0.474

0.474

M (sharp)

210

0.420

0.422

M

211

0.356

0.

301

0.282

0.288

360

M (broad)
M

0.275

311
400

0.237

0.237

W (sharp)

410

0.230

0.230

W

006

0.116

0.116

w
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Figure 2.1.
NMR spectrum of (AG)
in formyl-d formic
acid taken on a Bruker 500 MHZ NMR spectrometer. The
alanine a CH signal appears at 4.45 ppm and the CH3 peak is
observed at 1.36 ppm. The glycine a CH2 peak protons appear
at 4.05 ppm.
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WAVENUMBERS

(cm-1)

Figure 2.2. FTIR spectrum of silk II form of (AG)64- Amide
peaks at 1529 and 1629 indicate the 3-sheet architecture.
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Figure 2.3. X-ray diffraction photographs from poly (AG)
(a) With the x-ray beam directed parallel to the plane of
the compressed mat and with the mat normal horizontal. The
diffraction signals on this texture-oriented pattern index
on an orthorhombic unit cell with dimensions: a (hydrogen
bond direction) = 0.948 nm, jb inter-ap3 -sheet direction) =
Only hOO
0.922 nm, c (chain direction) = 0.695 nm.
diffraction signals occur on the meridian (vertical
The
bisector) and Okl on the equator (horizontal bisector)
(b) With
low angle diffraction signals are indicated by LX.
the x-ray beam directed orthogonal to the plane of the
In this case the diffraction signals are a
compressed mat.
set of concentric rings which index on the same orthorhombic
unit cell as in (a), c) SXDP of the poly(AG) model proposed
with alternating ±a/4 shears in the ac
by Fraser et
Notice the unwanted diffraction intensity on the
plane.
(d) SXDP of the chainfirst layer line (h=l) as indicated*
folded model shown in Figure 7 which incorporates random
=^±a/4 shears and alternating +c/2 and -c/2 shears in the ac
plane.
(

.
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Figure 2.4. Three-dimensional structure generated by a stack
of polar ap3-sheets of poly (AG)
They are arranged so that
like surfaces are in contact; thus the hydrophobic methyl
groups are layered between a pair of ap3-sheets, followed by
a layer of hydrogen atoms.
The unit cell is shown; note the
sheets are alternately sheared by ±a/4 in the ac plane. The
alternating deviation from the b/2 stacking periodicity is
evident and is, in part, responsible for the occurrence of
the 010 diffraction signal. The Jb-value is 3.8% greater
than that reported for oriented films of poly (AG) by Fraser
at al.^^ We believe this is due to steric interactions at
the regular (every eighth amino acid) Y"turns in our
structure (see Figure 2.7).
.
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Figure 2.5. View orthogonal (parallel to Jb-axis) to a single
ap3-sheet of poly (AG), folding in phase with the octapeptide
periodicity and forming Y"turns. The chains (c-direction)
run horizontally and the linear hydrogen bonds (shown as
dashed lines) are directed vertically (a-direction)
Note
that the conformations of the Y"turns are different at the
left-hand and right-hand edges (fold surfaces) of the appsheet.
The peptides connect through inward-pointing bonds
on the left and outward-pointing bonds on the right.
.

^'^
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Figure 2.6. Perspective view of a GAG Y"turn (from left-hand
side folds of Figure 2.5). The methyl groups of the alanine
residues on the underside of the ap3-sheet surface can be
clearly seen. The dashed lines represent the hydrogen
bonds.
Note the CH3 group at the apex of the Y"turn.
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Figure 2.7. A computer-drawn view of refined structure of
the chain-folded lamellar structure of poly (AG). The SXDP
of this structure is shown in Figure 2.3d and can be
compared with the experimental x-ray photograph shown in
Figure 2.3a.
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CHAPTER

3

DESIGN AND BIOSYNTHESIS OF ELASTIN-LIKE ARTIFICIAL

EXTRACELLULAR MATRIX PROTEINS CONTAINING PERIODICALLY SPACED
CS5/FIBR0NECTIN DOMAINS WHICH BIND HUMAN UMBILICAL VEIN
ENDOTHELIAL CELLS

3

.

1

Abstract
The biosynthesis of artificial extracellular matrix

proteins for use in vascular reconstruction has been
achieved.

These proteins are based on an elastin-like

pentapeptide repeat (VPGIG) periodically interspersed with
the CSS region of fibronectin.
(CSS (VPGIG)

20)5

and (CSS (VPGIG)

Both recombinant
40)

3

promote adhesion and

spreading of human umbilical vein endothelial cells
(HUVECs)

.

Although the binding domain (CSS) density is

twice as high in (CSS (VPGIG) 20)

5

as in (CSS (VPGIG)

40)

3,

the

number of HUVECs spread on the former is more than twice
that on the latter.

This is likely due not only to the

domain density, but to its availability based on the
conformation of the proteins on the surface.

This is the

first step in the synthesis of recombinant, artificial

extracellular matrix proteins for tissue reconstruction.

3

.

2

Introduction
Small diameter vascular grafts,

plagued by failure.

< 6mm in

diameter, are

Currently the optimal choice for

vascular reconstruction is autologous saphenous vein if it
49

is available and healthy; unfortunately, the patency
rate

after

5

years is only 70%/ Polytetraf luoroethylene (PTFE)

and polyethylene terephthalate (PET) are also commonly used
for small diameter vascular grafts; however, the patency

rate of these materials is lower than that of saphenous
vein.^ Failure most often occurs through thrombosis and

occlusion of the graft or through neointimal hyperplasia at
the anastomosis of the vascular grafts.^

Several techniques have been used to improve the

effectiveness of PTFE and PET grafts.
been directed toward achieving

a

Much of the work has

confluent layer of

endothelial cells on the luminal surface of the graft.
Since healthy vessels are lined with a layer of endothelial
cells, which provide a naturally nonthrombogenic interface,
it is thought that a similar layer on a synthetic surface

will also provide a naturally nonthrombogenic surf ace.

Taking this idea one step further, it is believed that a
combination of the biological nature of saphenous vein
(which is mechanically more similar to the artery that is to
be replaced than are the noncompliant synthetic materials)

along with the naturally confluent, luminal lining of

endothelial cells make saphenous vein superior to PTFE and
PET as a small diameter arterial replacement.^^

We have designed artificial extracellular matrix
proteins''^ exhibiting two main features.

They provide

structural support while providing sites for cell adhesion.
These proteins are elastomeric in nature due to blocks of
50

(VPGIG)

(the one letter amino acid code is used here and

will be used throughout)

.

modulus on the order of

1

(VPGIG)
x

10*'

is known to have a

dynes/cm

(depending on

crosslink density and water uptake)" which is similar to
that of native elastin, an extracellular matrix (ECM)
protein.

The materials also bind endothelial cells due to

the presence of the CSS region of fibronectin

(FN).'"

These

artificial extracelluar matrix proteins should provide

a

scaffolding for endothelial cells, which can attach and
proliferate, while the cells remodel the ECM to create a

natural environment.

The artificial ECM should also

maintain structural support until the seeded cells can
create a native extracellular matrix.
Two techniques are currently available to achieve a

confluent monolayer of endothelial cells on vascular grafts.
Endothelial cells can be induced to grow into the graft by

transinterstitial capillary ingrowth.

This has been shown

to be an effective means of endothelializing expanded PTFE
(with a 60

/im

internodal distance) in primates^^ and in

canines^^, but has not been shown to be an effective method

in humans.

The lack of capillary ingrowth in humans may

have to do with the thin, external, nonporous PTFE wrapping
found on PTFE grafts used for human vascular bypass

surgery .^^

A second technique used to create a monolayer of
endothelial cells on the luminal surface is to preseed the

grafts with endothelial cells.
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This can be done by

harvesting autologous endothelial cells and seeding
synthetic grafts immediately prior to

implantation;''^'''^ or,

autologous cells can be harvested, cultured and then seeded
onto the graft prior to implantation.

^"'^^

Recent data from

several laboratories has suggested that the patency rate on

these preseeded, synthetic vascular grafts is eguivalent to

that of saphenous

vein.^"'^^

The improvement in patency, in humans, of preseeded,

synthetic vascular grafts over those grafts which are
implanted denuded of endothelial cells suggests that seeding
of vascular grafts is indeed a method that, when employed

with new materials, may result in improved vascular
reconstruction.

We will herein describe the design,

synthesis and preliminary characterization of

novel

artificial extracellular matrix proteins that are expected
to provide not only structural support, but to bind

endothelial cells as well.
Structural support is provided by the pentapeptide

repeat (VPGIG)
(VPGVG)

,

,

a

variant of the pentapeptide repeat

which has been found to repeat up to 11 times

consecutively in native elastin."^

Polymers composed of

®°
these repeats exhibit an inverse temperature transition,

with a change in temperature causing an entropic expansion
or contraction of the material."

techniques Nicol et al

.

Using chemical synthetic

incorporated RGDS peptides into the

backbone of polymers based on the (VPGVG) peptide.

The

proteins were found to bind human foreskin fibroblasts and
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bovine aortic endothelial cells/'

In addition, proteins

based solely on (VPGVG) were found to be nonadhesive toward
these cell types.
The cell binding domain used here is the CS5 region of

fibronectin found in the alternatively spliced type III

connecting segment of fibronectin.

It is a 20 amino acid

long peptide found to promote cell binding.
al

.

Humphries et

found that melanoma cells adhere to the CS5 region

through the

a^Pi

integrin receptor; more specifically, the

receptors bound to REDV, the minimal sequence necessary for

recognition by

a^^i

,

contained in the CS5 region.

Massia and Hubbell demonstrated that human umbilical vein
endothelial cells (HUVECs) bind to the REDV peptide through
the

a^Pi

integrin receptor.''^ In further studies the authors

found that the orientation of REDV was quite important for

HUVEC adhesion.

GREDVY peptide attached to a glass surface

through the amine terminus promoted HUVEC binding while
peptide bound to the surface through the carboxyl terminus
was not adherent to HUVECs.

It was also shown that GREDVY-

grafted surfaces were adherent toward HUVECs, but not toward
^^'"^
smooth muscle cells (SMC), fibroblasts or platelets.

Due to the apparent specificity of REDV for endothelial

cells over other cell types regularly found in the
vasculature, it was chosen for the cell adhesion domain.
The entire CS5 region of fibronectin was chosen because it

was anticipated that the naturally occurring amino acids

surrounding the REDV domain would help to present the

5

sequence in such a way that it would be recognized by the
a^Pi

integrin receptor.

Nicol et al

found that chemical

.

synthetic incorporation of short REDV sequences into a

backbone made primarily of (VPGVG) repeats did not promote
adhesion to the REDV sequences by the

a^Pi

receptor in

HUVECs/^
Recombinant protein molecules containing either

a 20:1

or a 40:1 ratio of (VPGIG) :CS5 have been synthesized.

specifically, MG (CS5 (VPGIG) 20) sLE and MG (CSS (VPGIG)

40)

More

3LE have

been synthesized with the elastic portion spanning CSS

regions containing twice as many (VPGIG) repeats in the
latter as in the former.

Preliminary results show that

HUVECs do bind to these materials.

We find a S-fold

increase in the number of HUVECs bound to the (CSS (VPGIG20)

protein as compared to the (CSS (VPGIG)

40)

3

protein.

believed that this adhesion is through the
anticipated.

a43i

)

It is

receptor as

This achievement is the first step in the

design of precise materials for which biological recognition
elements are engineered in or out depending on the specific
intended use of the material.

3.3 Experimental Section

3.3.1 Materials
T4 DNA ligase, T4 polynucleotide kinase, calf

intestinal phosphatase, and all restriction enzymes were

purchased from New England Biolabs.
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Ribonuclease A,

.

Deoxyribonuclease

I,

ampicillin, kanamycin and

chloramphenicol were purchased from Sigma Chemical Co.

Escherichia coli strain DH5aF' was purchased from Bethesda
Research Laboratories.

Plasmid pUC18 and the XTT cell

counting kit were purchased from Boeringer Mannheim.

The

expression plasmid pET-28a and E. coli strain
BL21 (DE3) pLysS^^ were obtained from Novagen.

The HUVEC

lines and complete medium were purchased from Clonetics.

Falcon and Corning tissue culture dishes were purchased from
Fisher Scientific.

Versine EDTA solution for cell

detachment and M199 serum free medium were purchased from
Gibco.

3.3.2 General Methods

Bacterial growth in rich medium, DNA manipulations and

transformations were performed as described in Sambrook,
Frisch and Maniatis^^.

Polymerase chain reactions (PCR)

were run in a Techne cyclogene thermocycler

NMR spectra

.

were run on a Bruker AMX 500 MHZ spectrometer.

Cell density

measurements were done in plastic cuvettes with

a

length of

1

path

cm at X=600 nm on a Hitachi U2000

spectrophotometer.

HUVEC culturing was done according to

Clonetics protocol with the exception that cell detachment
was performed nonenzymatically using 0.02% EDTA (w/v)
Briefly, HUVECs were grown in polystyrene tissue culture

flasks with Clonetics EBM complete medium.
to 90% confluence prior to passaging.
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Cells were grown

Cells were passaged

1

to

6

(i.e.,

1/6 of the harvested cells were replated)

manipulations were performed in
cultures were incubated in 5%

a

CO^

All

.

laminar flow hood.

Cell

incubators at 37 °C.

Cell

counting was performed according to the Boeringer Mannheim
XTT cell counting kit instructions; absorption was measured
in disposable cuvettes with a path length of

cm

1

480 nm on a Hitachi U2000 spectrophotometer.

at X =

Briefly,

0.4 ml of EBM complete medium was added to each well

(containing HUVECs) of a 24 well plate; 0.2 ml of the XTT

reagent was then added to each well.

with the reagent in the

CO2

Cells were incubated

incubator for 20 hr prior to

reading the absorbance of the medium.

Hydrolysis for amino

acid analysis was done using propionic acid and 6.0 M

hydrochloric acid followed by derivatization with phenyl
isothiocyanate (PITC)
a

;

amino acid content was analyzed using

Waters Picotag System.

3.3.3 Preparation of Synthetic DNA

Oligonucleotides (1-3) were synthesized on a

1

/imol

scale on a Biosearch Model 8700 DNA synthesizer using

phosphoramidite chemistry.^®

Crude oligonucleotides were

purified by denaturing polyacrylamide gel electrophoresis
and eluted using the "crush and soak" method."

oligonucleotides were annealed at 80

""C

and allowed to cool

to room temperature over several hours.
duplexes: CS5 (1), 28ap (2), and (VPGIG)^
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Purified

The annealed
(3)

were

phosphorylated with T4 polynucleotide kinase, ethanol

precipitated and dried in vacuo.

(1)

Eco RI(Z) Sal
I

I

I

GEEIQIGHIPREDV

DYHL

AATTCTAAGTCGACGGTGAAGAGATCCAGATCGGCCACATCCCGCGTGAAGACGTTGACTACCACCTG
GATTCAGCTGCCACTTCTCTAGGTCTAGCCGGTGTAGGGCGCACTTCTGCAACTGATGGTGGAC
Ban
Y

Xho

Bam HI

II

I

P
I

I

TACCCGGGGGTGCCGCTCGAGG
ATGGGCCCCCACGGCGAGCTCCCTAG

(2)

Nco

Xho

I

I

Z

I

Z

Sal

I

I

I

CCATGGGCCTCGAGTAATAAAG
CCGGAGCTCATTATT TCAGCT

(3)

Eco RI
j

Z

Ban

GjVPGIGVPGIGVPGIGVPGI
I

AATTCTAAGGGGTGCCGGGTATCGGCGTTCCGGGCATCGGTGTACCGGGCATCGGTGTTCCGGGCATC
GATTCCCCACGGCCCATAGCCGCAAGGCCCGTAGCCACATGGCCCGTAGCCACAAGGCCCGTAG
Ban

I

Bam HI

gvpgig|vp|
ggtgttccgggtatcggggtgccgg

ccacaaggcccatagccccacggccctag

3.3.4 Cloning and Amplification of Synthetic DNA

Purified CSS DNA was ligated into Eco RI/Bam HI

digested pUC18 and used to transform E. coli strain DHSaF'.
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Cells were grown at 37

°C

overnight on 2xYT solid medium

containing 200 nq/ml ampicillin, 25

/ug/ml 3-

isopropylthiogalactoside (IPTG) and 40

iiq/ml of the

chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-Dgalactopyranoside (X-Gal) for blue-white screening.

Plasmid

DNA from white transf ormants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the

insert.
1

After isolation of the recombinant plasmid from a

liter 2xYT culture, the CS5 DNA was excised by digestion

with Eco RI and Bam HI and the fragments were separated by

nondenaturing polyacrylamide gel electrophoresis.

DNA

monomer was eluted from the polyacrylamide gel by the "crush
and soak" method."

Similarly purified (VPGIG)5 DNA was ligated into Eco

RI/Bam HI digested pUC18 and used to transform E. coli
strain DH5aF'.

Cells were grown at 37 °C overnight on 2xYT

solid medium containing 200

/Ltg/ml

ampicillin, 25 /xg/ml p-

isopropylthiogalactoside (IPTG) and 40

/xg/ml of the

chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-Dgalactopyranoside (X-Gal) for blue-white screening.

Plasmid

DNA from white transf ormants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the
insert.
1

After isolation of the recombinant plasmid from a

liter 2xYT culture, the (VPGIG)5 DNA was digested with

Ban

I

and the fragments were separated by nondenaturing

polyacrylamide gel electrophoresis.
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DNA monomer was eluted

from the polyacrylamide slice, using the "crush and soak"

method."
Purified 28ap was ligated into Nco I/Xho

I

digested

pET-28a and used to transform E. coli strain DH5aF'.

Cells

were grown overnight on 2xYT solid medium containing 34
/xg/ml kanamycin.

Plasmid DNA from single colonies was

sequenced using Sequenase 2.0 (Amersham Life Sciences) to

verify the identity of the insert.

The recombinant plasmid

was designated pET-28ap.

3.3.5 Cloning of CSS in Transfer Vector

Purified CSS monomer was ligated into Bam HI/Eco RI

digested pEC2 plasmid DNA (shown in appendix

A)

.

The

resulting plasmid (designated pEC2-CS5) was used to

transform E. coli strain DHSaF'.

Cells were grown overnight

on 2xYT solid medium containing 34 nq/ml kanamycin.

Plasmid

DNA from single colonies was verified for CSS insert by Bam

HI/Eco RI digestion followed by 1% agarose gel
electrophoresis and visualization of the DNA with ethidium

bromide (EtBr)

.

The expected band was observed at 100 bp.

3.3.6 Polymerization of the (VPGIG)5 Monomer and Cloning of
(VPGIG)5 Multimers

Purified monomeric (VPGIG)5 DNA was self-ligated with
T4 DNA ligase to form a population of multimers.

were ligated into Ban

I

Multimers

digested, dephosphorylated pEC2-CS5.

The recombinant plasmids were used to transform E. coli
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^

.

strain DH5aF

•

Transf ormants were screened by PCR" with

.

cycling times and temperatures as follows: 96
45 °C,

min; 72°C,

2

was used with Pst
Biolabs)

I

2

min with 35 cycles.

l

min;

Vent polymerase

site primers for pBR322 (New England

Clones encoding

.

°c,

4

and

8

repeats of the (VPGIG)5

monomer were chosen and the recombinant plasmids were

designated pEC2-CS5 (VPGIG) 20 and pEC^-CSS (VPGIG)

40

respectively

3.3.7 Construction of Bacterial Expression Vector

Recombinant pEC2-CS5 (VPGIG) 20 or

digested with Xho I/Sal
cassette.

I

pEC2-CS5 (VPGIG)

40

was

to release the CSS (VPGIG)

The cassettes were separated by 1% agarose gel

electrophoresis and recovered by extraction with Qiaex II
DNA extraction kit (Qiagen)
into Xho

I

.

The recovered DNA was ligated

digested, dephosphorylated

transform E, coli strain DH5aF'.

pET-28ap and used to

Transf ormants were

screened for the presence and orientation of each multimer
by Pflm I/Xho

I

digestion.

Digested DNA was visualized with

EtBr following 1% agarose gel electrophoresis.

Bands

comprising 430 base pairs plus the length of the insert
indicate DNA insertion in the correct orientation.

This

process was performed repeatedly to obtain recombinant
plasmids, designated pET-28ap- (CS5 (VPGIG) 20) 5 or pET-28ap(CS5 (VPGIG)

40) 3,

which were used to transform the expression

host, E. coli strain BL21 (DE3)pLysS.
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5

3.3.8 Protein Expression, Batch Phase, Rich Medium

Single colonies of BL21 (DE3) pLysS containing

recombinant pET-28ap- (CS5 (VPGIG) 20)
(CS5 (VPGIG)

40)

3

.

to inoculate

or pET-28ap-

were used to inoculate 10 ml of 2xYT medium

containing chloramphenicol
(34 /Ltg/ml)

5

and kanamycin

(34 /xg/ml)

The cultures were grown to saturation and used
1

L volumes of 2xYT medium containing

chloramphenicol (34

/Lig/ml)

cultures were grown to

and kanamycin (34

ODgoo =

1

at 37

/iig/ml)

The

.

C and protein

expression was induced by the addition of IPTG to a final
concentration of 1.0 mM.

Cells were harvested after

by centrif ugation (5,000 x g, 15 min at

4 °C)

.

hours

3

The cell

pellets were resuspended in 15 mL of TEN (50mM Tris-Cl
(pH 8.0),

1

mM EDTA, 100 mM NaCl) and

3.3.9 Purification of (CSS (VPGIG)

stored at -20

C.

20)

Frozen cells were thawed and phenylmethyl sulfonyl

fluoride (PMSF)
DNAse (20

/xg/ml)

(1 mM)

,

MgCl2

(5 mM)

,

RNAse (20

were added to the suspension.

resulting solution was incubated at

^JLq/ml)

and

The

37 °C for 30 min and the

soluble portion was recovered by centrif ugation (10,000 x
4 °C,

30 min).

g,

The supernatant was acidified to pH 5.0 by

addition of 0.1 N HCl and left at room temperature for

1

hr.

The suspension was centrif uged at 10,000 x g for 20 minutes
at room temperature to recover the precipitate.

was resuspended in

temperature for

1

5

hr,

ml

1

The pellet

M urea and incubated at room

then centrif uged at 10,000 x g for 20

3

min to recover the soluble portion.

The supernatant was

dialyzed (25,000 molecular weight cut off (MWCO) dialysis
tubing, Spectrapore) against H2O at

changes.

°C for 2

4

days with H^O

The dialysate was centrifuged to remove impurities

and the supernatant was lyophilized to recover the

recombinant (CSS (VPGIG) 20)

5.

3.3.10 Purification of (CSS (VPGIG)

40)

Frozen cells were thawed and phenylmethyl sulfonyl

fluoride (PMSF)

(1 mM)

,

MgCl^ (S mM)

RNAse (20 iiq/ml) and

,

DNAse (20 /xg/ml) were added to the suspension.

was incubated at 37

°C

for

30

min and the insoluble portion

was recovered by centrif ugation (10,000 x
The pellet was resuspended in IS ml
at room temperature for

1

g,

4

°C,

30 min).

M urea and incubated

then centrifuged at 10,000 x g

1 hr,

20 min to recover the soluble portion.

for

The solution

The

supernatant was dialyzed (25,000 MWCO dialysis tubing,
Spectrapore) against H2O at
changes.

°C for

4

3

days with H2O

The dialysate was then centrifuged to remove

impurities and the supernatant was lyophilized to recover
the recombinant (CSS (VPGIG)

40)

3

•

3.3.11 Film Casting

Glass coverslips (12 mm) were coated with
(CSS (VPGIG)

20)

5

or (CSS (VPGIG)

or water by addition of 40

40)

/xl

3

from solutions in formamide

of a

1

mg/ml solution to the

top surface of the coverslip followed by spreading of the
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solution with the tip of a pipet. Fibronectin films were
cast from 100 nq/ml solutions in distilled H^OCdH.O); 20

iil

of solution was applied to a glass coverslip and spread
with

the tip of a pipet. All coverslips were then dried at 55 °c
in a vacuum oven. Coverslips were incubated in 0.5 ml

sterile H2O at 37

°C for 2

hours to remove excess protein

and again dried in vacuo at 55 °C for

2

hours.

3.3.12 Cell Culturing

Pooled primary HUVECs were cultured and maintained in

Clonetics EBM complete medium in 10 cm Falcon tissue culture

polystyrene petri dishes.

HUVECs from passages 2-10, in our

hands, were used for all cell adhesion studies.

washed with

5

ml

Cells were

phosphate buffered saline (PBS) once and

then harvested using Versine, a 0.02% EDTA solution in PBS.

Harvested cells were resuspended in serum free M199 medium,
counted using a hemocytometer and diluted to a density of
1

X

10''

dishes,

cells/ml.
1

x

coverslips.
4

10''

HUVECs were transferred to 24 well

cells/well, containing protein coated glass

Cells were maintained at 37 °C and 5% CO2 for

hours and counted using XTT following the Boeringer

Mannheim XTT kit protocol.

Briefly, glass coverslips

containing attached cells were removed from the culture
well, washed three times with phosphate buffered saline +
CaCl2

(0.2 g/L)

24 well plates.

and MgCl2 (0.2 g/L)

(PBS+)

and placed in new

Endothelial cell medium, phenol red free,

(0.4 ml, Clonetics)

and 0.2 ml of cell counting reagent were
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added to each well.
incubator for

20

Cells were returned to the CO2

hr.

The absorbance of the supernatant was

then read at 460 nm.

3.3.13 Cell Counting Calibration

Calibration curves were made during each cell culturing
experiment.

HUVECs were cultured at the following

concentrations

(2

wells each) in serum free medium: 10,000;

7,500; 5,000; 2,500; 1000; 750; 500; and 250 cells/well.

Cultured cells were maintained in an incubator, 37
CO2,

for

4

hours.

After

°C and 5%

hours the medium was removed; the

4

HUVECs were washed with 0.5 ml PBS and 0.4 ml of medium

containing serum, and 0.2 ml of cell counting reagent was
added to each well.

The calibration wells were maintained

and evaluated as described above.

3.3.14 Cell Adhesion after Removal with Trypsin

Removal of HUVECs from polystyrene dishes was performed
as recommended by Clonetics.

3.4 Results and Discussion

3.4.1 Gene Construction

The strategy used in our laboratory to prepare

artificial proteins has been described previously

In

.

this work, DNAs encoding two chain-length variants of
CS5(VPGIG), which contain

5'

Sal
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I

cohesive ends and

3'

Xho

)

I

cohesive ends were ligated into the Xho

I

site of the

expression plasmid pET-28ap. The cohesive ends generated by
Xho

and Sal

I

I

digestion are the same, and hence can be

ligated; however, the flanking base pairs are different, so

once the ends are ligated the Sal

destroyed.

I

and Xho

This process maintains an Xho

I

I

sites are

site at the

3'

end of the gene for addition of DNA cassettes, while

eliminating other restriction sites in the gene so that it
will not be cut into pieces upon enzymatic digestion with
Xho

I.

This strategy allows for ease in construction of

longer genes.

The resulting recombinant plasmids encode

either (CS5 (VPGIG) 20)

5

or (CS5 (VPGIG)

40)

3

(4)

and

(5)

respectively.

MG(LDGEEIQIGHIPREDVDYHLYP(GVPGI)2o) 5LE

(4)

MG (LDGEEIQIGHIPREDVDYHLYP (GVPGI

(

)

40)

3LE

5

These genes are constructed in such a way that upon

translation into protein only minimal amino acid fusions are
A methionine

added to the ends of the protein of interest.

residue must always be added as it indicates the

translational start; in addition a glycine residue is added
to the start as a result of the use of the Nco

cloning.

I

site in

Two amino acids are also added to the amino

terminus due to cloning into the Xho

I

site.

These

additions result in minimal amino acid fusions.

•

3.4.2 Protein Expression

The host used for protein expression was E. coli strain

BL21 (DE3)pLysS.^^

In this strain, a gene encoding T7 RNA

polymerase is incorporated into the bacterial chromosome
under lacUVB control, and protein production is induced by
the addition of IPTG.

The pLysS plasmid provides low levels

of T7 lysozyme, which inhibits T7 RNA polymerase and

suppresses the basal level of protein expression.
Protein expression in rich medium was performed as

described in the Experimental Section.

Aliquots of cultures

representing approximately equal numbers of cells (as

determined by the optical density at 600 nm

- 0D,,„„)

were

removed periodically after induction of protein synthesis
(t= 0 - 180 minutes)

.

Samples were loaded on a 10%

polyacrylamide gel and separated by electrophoresis.
Protein bands were stained with Coomassie Brilliant Blue RThe recombinant protein does not stain well; however

250.

it forms a pale blue band which, owing to over-expression

and consequent distortion of the adjacent electric field,

appears to compress lower molecular weight protein bands, as
can be seen near 65,000 da (CS5 (VPGIG)

^o)

3

(Figure 3.1).

Figure 3.1 is a 10% polyacrylamide gel containing whole cell
lysate samples of BL21 (DE3) pLysS pET-28ap- (CS5 (VPGIG)
Lane

contains molecular weight standards while lanes

1

through
t =

1

40)

5

3

2

contain whole cell lysate from cultures at t =

hr, t =

2

hr and t =

3

hr respectively.

band corresponding to (CS5 (VPGIG) 40)
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3

0,

A pale blue

(molecular weight

59,765 da) can be seen to grow in over the observed

observation period.

3.4.3 Protein Purification and Analysis
For cultures grown to
(CS5(VPGIG)4o)

1

OD^oo = 0.8,

60 mg/L of

and 40 mg/L of (CS5 (VPGIG)

20)

weight 56,984 da) can be recovered through

5

(molecular

a

simple

procedure involving selective precipitation of contaminating

proteins below the lower critical solution temperature of
the target protein.
The
(CSS (VPGIG)

and
20)

5

^^C

NMR spectra of (CS5 (VPGIG)

in formic acid (Figures 3.2

the presence of the (VPGIG) repeat.

&

40)

j

3.3)

and

indicate

As the CS5 regions of

the molecules represent only a few percent of the entire
protein, they are not easily detected by ID NMR; and

therefore the peaks corresponding to those amino acids are
not seen in
and

5

Figures 3.2a and 3.3a.

Splitting of the

3,

y

Pro CH2 can clearly be seen near 3.8-4.0 and 2.0-2.5

ppm due to cis trans isomerization

.

®

Only one Gly CH2 is

resolved at 2.5 ppm in the proton spectrum; however, both
glycine residues in the pentapeptide repeat are resolved in
the carbon spectrum and are seen as two distinct peaks at
45-46 ppm (Fig. 3.2b

&

These spectra compare quite

3.3b).

nicely with spectra obtained by McPherson et al

.

of

recombinant (VPGVG)^, save that of isoleucine peaks

replacing the peaks due to the 4th valine residue as
result of substitution of

He

a

for Val in the pentapeptide.^
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Table 3.1 shows amino acid analysis results for
(CSS (VPGIG)

and (CS5 (VPGIG)

40)3

20) s-

Both analyses are in

agreement with the expected protein compositions within the

uncertainty of the measurement.

Experimental values

indicate that both the amino acids of the CSS region and the

amino acids of the (VPGIG) region are present in the correct

ratios as are as expected from NMR spectra.

The absence of

unassigned peaks in the NMR spectra, combined with the amino
acid analysis, are consistent with sample purity.

3.4.4 HUVEC Adhesion and Spreading

Table

culturing

3

.

lO''

2

contains cell counting data obtained from

HUVECs per well in 24 well culture dishes (as

described above)

Each well contained a glass coverslip

.

coated with protein.

fibronectin

(FN)

As shown,

(CSS (VPGIG)

20)

5

and

coated coverslips bind nearly all of the

cells plated into the well.

The value for (CSS (VPGIG) 20)

5

cast from H2O is higher than the number of cells plated into

each well; 11,760 cells were counted while only 10,000 were
plated.

This can be explained by

a

small amount of cell

growth during the 20 hour incubation time with complete

medium and XTT cell counting reagent.

Significantly fewer

cells are seen to attach to (CSS (VPGIG)

40)

and from formamide.

3

cast from water

There are relatively few cells attached

to the glass surface.

Figures 3.4a-e show HUVECs on the surfaces after
hours, prior to rinsing with PBS.
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4

Greater numbers of HUVECs

are seen on the (CS5 (VPGIG)

20)

5

surfaces cast from formamide

(Figure 3.4b) and from water (Figure 3.4c) as compared to

the other surfaces.

The majority of the cells are spread or

spreading as judged from their nonref ractile nature.
cells are retained on the (CSS (VPGIG) 40)

3

Fewer

surfaces cast from

formamide (Figure 3.4d) and water (Figure 3.4e) but, again,
the majority of the HUVECs are spread or spreading.

Although a similar number of HUVECs appear on the glass
surface (Figure 3.4a) and on the (CSS (VPGIG)

40)

3

surfaces,

the majority of the cells on the glass surface are not

adherent as judged from the highly refractile images of the
cells.

The artificial extracellular proteins promote cell

attachment and spreading.
Urry and colleagues chemically synthesized

poly{20 (GVGVP)

,

(GREDVP)

}

.

These proteins are random block

copolymers where the ratio of (GVGVP) to (GREDVP) is 20 to
1.

They found no adhesion of HUVECs or of A37S melanoma

cells, which are known to express

oc^^i,

to these materials.

This result may be due to the short (GREDVP) peptide not

achieving the proper conformation for binding to

a43i.

Hubbell and colleagues have observed HUVEC spreading on

glycophase glass which has been modified through N-terminal

grafting of GREDVY peptides to the surface at a

concentration of approximately 10 pmol/cm^"^

They report

the percentage of attached cells that are spread, but do not

report the number of cells that are attached.

They also

fail to report their criteria for attachment or how to
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.

define attached vs nonattached/^ These uncertainties make
accurate comparison of results difficult; however, as

determined from protein stability results reported in
chapter

4,

19 ±

2

pmol/cm' of (CSS (VPGIG)

the glass coverslips.

20)

5

is present on

Assuming that HUVECs have access to

o

the top 10 A of the recombinant protein film, there is 10
2

±

pmol/cm' of CS5 ligand available for adhesion (comparable

to that achieved by Hubbell at al.).^^

The attachment and

spreading of HUVECs to (CSS (VPGIG) 40) 3 and (CSS (VPGIG) 20)

consistent with the results of Hubbell at al

.

5

are

and

attributable to adhesion of the HUVECs to the CSS region.
There are significant differences in the number of
cells attached to surfaces cast from (CSS (VPGIG) 20)

surfaces cast from (CSS (VPGIG)

40) 3-

5

and

Although the receptor

density in the former is only twice the density of the
latter, more than twice as many cells attach and spread on
(CSS (VPGIG)

3.2).

20)

5

(

=

10,000) as on (CSS (VPGIG)

40)

3

(

= 2000)

(Table

This is likely due not only to the density of the

receptor in the protein itself, but to the accessibility of
the receptor once the protein has adhered to a surface.

While the two artificial proteins are quite similar in

primary structure, it is probable that upon adhesion to
glass surfaces their secondary and tertiary structures

become quite different; thus the CSS domain in
(CSS (VPGIG)

40)

3

may not be as accessible to the HUVECs as it

is in the (CSS (VPGIG)

20)

5

protein, due to conformational

differences
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Figure

3

.

5a-f show HUVECs that were harvested using

trypsin (Figure 3.5a, 3.5c, 3.5e) and HUVECs that were

harvested using EDTA (Figure 3.5b, 3.5d, 3.5f) spreading on
glass,
1

(CS5(VPGIG)2o)s/ or (CSS (VPGIG)

hour in serum free medium.

^o)

3

surfaces after

It is evident in all cases

that HUVECs removed from polystyrene culture dishes using

trypsin do not spread as well as HUVECs removed with EDTA.
The difference in spreading of nonenzymatically vs

enzymatically harvested cells on (CSS (VPGIG) 20)
formamide is striking (Figures 3.5c,

adhesion to (CSS (VPGIG) 20)

5

d,

5

cast from

e and f )

is mediated by the

If the

.

integrin

ot^^i

receptor, as expected, then this difference in adhesion can

Masumoto and Hemler found that trypsin

be explained.

cleaves the extracellular domain of the
subunit.^^

Cleavage of the

inhibit binding by

ot^^i

ol^

a4

integrin

subunit by trypsin would

to CSS.

3.5 Conclusions

The biosynthesis and purification of (CSS (VPGIG) 20)
(CS5 (VPGIG)

40)

3

5

and

have been successfully achieved as indicated
and

NMR

by polyacrylamide gel electrophoresis,

^H

spectroscopy and amino acid analysis.

The proteins induce

the adhesion and spreading of HUVECs.

It is likely that the

adhesion is through

oi^^i

^^C

integrin recognition of the CSS

block of the proteins.
It is possible to synthesize artificial extracellular

matrix proteins using recombinant DNA techniques.
71

These

proteins can be designed in such a way that they provide
support for the growing cells and provide biological signals

specific for these cells.

We have demonstrated that we can

design and synthesize elastin-like materials which contain

binding sites for HUVECs.

The number of binding sites is

readily varied to control the initial density of the seeded
cells.

This approach may be important in the reconstruction

of tissues and organs.

The technique described herein is not limited to

building in a single biological signal.

It is equally

possible to choose specifically several signals and build
these simultaneously into one or, should this approach prove

more desirable, into

a

selected number of different

artificial extracellular matrix proteins.

The current work

is a first step in the biosynthesis of biological

scaffolding for the reconstruction of blood vessels.
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Table 3.1 Amino Acid Analyses of (CSS (VPGIG) 20)

5

and (CS5(VPGIG)4o)5

(CSS (VPGIG)
3.(ni.no

theor

20)

s

AO)

tneor *

expl

^

expl

acids

ASP + ASN

2.44

2.22

1,34

2.31

GLU+GLN

3.42

3.03

1

94

3.25

SER

.

0.37

0.64

GLY

34.36

34.01

HIS

1.63

1.19

0.9

0.95

ARG

0.81

0.89

0.45

0.82

36.87

33.93

THR

0.35

0.005

ALA

0.72

1.11

PRO

16.29

17.27

18.8

16.92

TYR

1.63

1.34

0.9

1.09

VAL

17.

17.61

17.73

0.16

0.16

0.15

0.21

ILE

18.73

18.06

19.25

17.77

LEU

1.79

1.92

1.04

1.79

MET
CYS

PHE

0.21

0.30

LYS

0.44

0.62
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Table 3.2 Number of HUVECs on Surfaces after
4

Hours in Serum Free Medium

Number of Cells on

Protein

/

Cast From

Surface

Glass

2,880

+

1670

9, 170

+

1800

11,700

+

760

(CS5(VPGIG)2o)5

/

Formamide

(CS5(VPGIG)2o)5

/

Water

(CSS (VPGIG)

40)3

/

Formamide

1,150

+

360

(CS5(VPGIG)4o)3

/

Water

2,590

+

570

10, 140

+

290

Fibronectin
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Figure 3.1 A 10% SDS-PAGE of (CSS (VPGIG) ^o) 3 whole cell
lysate is shown. Lane 1 contains molecular weight marker,
bands from top to bottom: 200, 97.4, 68, 43, 29, 18.4, &
14.3 kDa.
Lanes 2-5 contain whole cell lysate of t = 0, t =
hrs respectively. The recombinant protein
1^ t=2,
can be seen as a pale blue band growing into lanes 3-5 at 68

&t=3

kDa.
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1.5

l.O

ppin

2b

Figure 3.2. NMR spectra of purified (CSS (VPGIG) 40) 3 in
formyl-d formic acid. 3.2a shows the 500 MHz proton NMR
Identification
spectrum; all peaks are identified as shown.
of all peaks is consistent with assignments made by
with the exception of the isoleucine
McPherson at al
3.2b
chemical shifts which were assigned independently.
shows the carbon-13 spectrum. Only the resonances from the
major amino acid components (VPGIG) can be seen.
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Figure 3.3. NMR spectra of purified (CS5 (VPGIG) 20) s in
formyl-d formic acid. 3.3a shows the 500 MHz proton NMR
identification of all peaks is consistent with
spectrum;
with the exception of
assignments made by McPherson et al
the isoleucine chemical shifts which were assigned
3.3b shows the carbon-13 spectrum. Only the
independently.
resonances from the major amino acid components (VPGIG) can
be seen.
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Phase contrast images of HUVECs spreading on a)
Figure 3.4.
glass, b) (CS5 (VPGIG) ,o) s cast from formamide, c)
cast from
(CS5(VPGIG)2o)5 cast from water, d) (CS5 (VPGIG) ,o) 3
formamide, and e) (CSS (VPGIG) ,0) 5 cast from water.
78

'J.

d.

o
O

-

e)0

harvested with
Figure 3.5. Phase contrast images of HUVECs Images show
Trypsin (5a, 5c, 5e) or EDTA (5b, 5d, 5f
from
,o) s cast
spreading on: a&b) glass, c&d) (CS5 (VPGIG)formamide.
formamide, e&f) (CS5 (VPGIG) ,o) 3 cast from
)
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CHAPTER

4

RECOMBINANT ARTIFICIAL EXTRACELLULAR MATRIX PROTEINS:
CHARACTERIZATION AND CELL

4

.

1

-

BINDING BEHAVIOR

Abstract
Recombinant artificial extracellular matrix proteins

have been evaluated as materials for use in the design of
new vascular prostheses.
(CSS (VPGIG)

b

Two proteins (CSS (VPGIG)

.,o)

,

and

which contain the CSS region of fibronectin,

known to bind to the

a^^-^

integrin receptor/' and an elastin

like pentapeptide (VPGIG)

have been cast into films upon

which human umbilical vein endothelial cells (HUVECs) were
cultured.
of HUVECs.

These proteins promote the adhesion and spreading
The number of cells adherent to the surface is

dependent on the density of the CSS domain with
(CSS (VPGIG)

2o)

5

exhibiting

cells as (CSS (VPGIG)

4o) 3*

5

times the number of adhered

The extent of individual cell

spreading is seen to be similar on both materials.

Adhesion

of HUVECs to these materials supports the formation of actin

filaments as shown by fluorescent staining of the actin.
The existence of the LOST in both materials suggests that

they retain the properties of the elastin-like backbone

despite the periodic insertion of CSS.

4.2 Introduction
It has been well documented that cells respond to the

surface with which they are in contact.
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These surfaces may

be biological in nature and thus contain biospecific

moieties that signal the cells to respond in

a

defined

manner, or they may be synthetic materials that, due to

their chemical or physical properties, signal the cells in a

nonspecific fashion.

Grande et al

.

demonstrated that

chondrocytes cultured in vitro on polyglycolic acid produce
proteoglycans, while chondrocytes cultured on type

collagen produce primarily collagen/'^ Peluso et al

I
.

found

that poly (hydroxyethyl methacrylate) P(HEMA) supported

minimal fibroblast attachment and spreading, while an
interpenetrating polymer network containing 10 wt

polycaprolactone and 90

%

P(HEMA)

%

induced cell spreading and

stimulated a 4-5 fold increase in collagen production by the
fibroblasts.®^
CH2OH,

CONH2,

By

f unctionalizing

polyethylene with COOH,

and CH2NH2 groups (using corona discharge

treatment), Lee et al

.

found that they could change the

ability of Chinese hamster ovary cells to adhere, spread and

grow on the surfaces; the positively charged CH2NH2 surface
was found to maximize these behaviors.®^ By altering the

surface charge of poly (vinylidene fluoride) (PVDF)

,

Bouaziz

et al. demonstrated that the secretion of prostacyclin and

thromboxane by endothelial cells cultured on these surfaces
varied; PVDF with a piezoelectric coefficient of 25pCN

showed the highest prostacyclin

:

Thromboxane A2 ratios.

Controlling the behavior of the cells on surfaces
offers the best possibility for the reconstruction of

tissues and organs.

Artificial extracellular matrix
81

^

5

.

proteins can be designed with built-in control of both the

mechanical and biological properties of the resulting
material.

Recombinant DNA technology provides a powerful

technique with which these novel artificial extracellular

matrix materials can be synthesized.
reported the synthesis of
and (CSS (VPGIG)

region of

40) 3,

We have previously

two such proteins:

(CS5 (VPGIG)

20)

in which the CS5 designates the CS5

f ibronectin.

The REDV sequence, contained

within the CSS peptide, was shown to be the minimal sequence
necessary to bind to the
found that the

a43i

a43i

Massia at al

integrin.""

integrin is present in human umbilical

vein endothelial cells (HUVECs) and that this HUVEC receptor
adheres to both soluble and surface-grafted GREDVY
peptide.''^ The authors also reported that the peptide does

not promote the adhesion and spreading of fibroblasts,

smooth muscle cells (SMC) or platelets when bound to

glycophase glass. ^^'''^
In our biosynthetic constructs the (VPGIG)

provides the mechanical support.

The (VPGIG)

^

block
structural

block is based on the pentapeptide (VPGVG) which, when

polymerized has been shown by Urry to have mechanical
properties similar to those of native elastin.®^ These

proteins are elastomeric in nature due to blocks of (VPGVG)
known to have a modulus on the order of

1

x 10^ dynes/cm^

(depending on crosslink density and water uptake)^ similar
to native elastin, an extracellular matrix (ECM) protein.

These new artificial extracellular matrix proteins are
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expected to provide structural support while promoting
the
adhesion and spreading of HUVECs through the a^^^ integrin
receptor.

It is also anticipated that they will selectively

bind HUVECs and not fibroblasts, platelets and SMC due to
the specificity of the REDV peptide. ^^'"^ In addition, a

similar polymer,

(VPGVG)^, was found by Nicol et al

.

not to

support the adhesion of ligamentum nuchae fibroblasts, human

malignant melanoma cells and HUVECs. "^'"^
As reported in the previous chapter, HUVECs adhere to
(CSS (VPGIG)

40)3

and (CSS (VPGIG) 20)

5.

This adhesion is thought

to be moderated by the REDV sequence contained in the CSS

block of the proteins. These novel materials also promote
the spreading of HUVECs and support cell growth and

monolayer formation.
It has been reported that similar proteins based on
(VPGVG)x, when crosslinked using gamma-irradiation, exhibit

elastomer ic properties. ^^'^^ By analogy, the present

artificial extracellular matrix proteins are expected to be

elastomer ic in nature.

HUVEC adhesion and elasticity are

favorable qualities for vascular prostheses.

These grafts

would be expected to provide elastic recoil during diastole,
match the compliance of native artery, and promote the
formation of a confluent endothelium.

These proteins are

the first step in the design of vascular grafts that will

promote cell adhesion and growth as well as provide

mechanical support which is similar to that found in native
arteries.

Furthermore, such materials are expected to
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,

,

degrade into nontoxic biological molecules which
can then be
utilized by the body in protein production while the
cells
are remodeling their own extracellular matrix.
Finally,

materials based on the pentapeptide (VPGVG)
as well as crosslinked poly (VPGVG)

,

poly(VPGVG)^

(20 mrad y-irradiation)

have been subjected to extensive biomaterials testing,
including determination of mutagenicity (Ames test)

toxicity (mice and rabbits)

,

antigenicity (Guinea pigs)

pyrogenicity (rabbits) and thrombogenicity (dogs) and have

performed well in each of these tests. ®^

4.3 Experimental Section

4.3.1 Materials

HUVEC and human aortic SMC lines as well as medium were

purchased from Clonetics.

M199 serum free medium and

Versine were purchased from Gibco.

The XTT cell counting

kit was purchased from Boeringer Mannheim.

Falcon 10 cm and

Corning 24 well tissue culture dishes and 12 mm glass cover
slips were purchased from Fisher Scientific. Mouse

monoclonal anti human
Technologies.

a4

(P4G9) was purchased from Life

Mouse anti human

monoclonal B-5G10 was a

kind gift from Martin Hemler at the Dana Farber Cancer
Institute.

Oregon Green™ 488 phalloidin was purchased from

Molecular Probes.

Vecta Shield mounting fluid was obtained

from Vector Research Laboratories.

The GREDVDY peptide was

obtained from Research Genetics, Inc.
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Ultima Gold

scintillation counting fluid was purchased from Packard
Instrument Company.

4.3.2 General Methods

HUVECs were maintained in EBM complete medium
(Clonetics) and SMC in SmGM Bullet kit {containing basal

medium, 10 Mg/L Epidermal Growth Factor,

/xg/L

2

Fibroblast

Growth Factor, 0.39 mg/L Dextramethasone, 50 mg/ml
Gentamicin, 50 mg/ml Amphotericin-B, and 10

serum (Clonetics)

}

in a humidified,

3)

Fetal Bovine

5% CO2 incubator at

37 °C as specified by Clonetics' protocol

in chapter

%

(described briefly

with the exception that cell detachment was

performed nonenzymatically

.

Cloud point curves were

obtained in distilled water in quartz cuvettes with a

pathlength of

1

mm at X = 300 nm on a Jasco Model J-715

spectropolarimeter equipped with a Peltier type temperature
control system; Jasco J-700 for Windows software was used
for data analysis.

Scintillation counting was performed

using a Beckman Instruments, Inc. LS 1800 scintillation
counter.

Confocal images were obtained with a BioRad MRC

1000 confocal microscope.

4.3.3 Protein Expression, Batch Phase, M9AA Medium

Single colonies of E. coli strain BL21(DE3)pLysS

transformed with recombinant pET-28ap- (CSS (VPGIG) 20)

5

or pET-

28ap-(CS5(VPGIG)4o)3 (cf. previous chapter) were used to

inoculate

5

ml of M9AA medium containing chloramphenicol
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5

,

(34 /ig/ml)

and kanamycin (34

/Lig/ml)

The cultures were

.

grown to saturation and used to inoculate 0.5 L volumes of

M9AA medium containing chloramphenicol
kanamycin (34 ng/ml)

and

(34 /xg/ml)

The cultures were grown to

.

ODgoo =

0.8

at 37 °C and protein expression was induced by the addition
of IPTG to a final concentration of 1.0 mM;

(0.13-0.27 mmol)

Cells were harvested after

by centrifugation (5,000 x g, 15 min at

pellets were resuspended in
1

1

^,Ci/^l

glycine was added for radiolabeling of

the artificial protein.

8.0),

ml

2

4

°C)

.

3

hours

The cell

mL of TEN (50mM Tris-Cl (pH

7

mM EDTA, 100 mM NaCl) and

stored at -20

4.3.4 Protein Purification (CS5 (VPGIG)

40)

3

°C.

and (CS5 (VPGIG) 20)

Frozen cells were thawed and phenylmethyl sulfonyl

fluoride (PMSF)
DNAse (20

(1 mM)

/Ltg/ml)

at 37 °C for

30

,

MgCl2

(5 mM)

were added.

RNAse (20 /ig/ml) and

,

The solutions were incubated

min and the insoluble portion was recovered

by centrifugation (10,000 x

g,

was resuspended in 7.5 ml

M urea

1

4

30 min).

°C,

(

(CS5 (VPGIG)

The pellet
20)

5

is found

in the insoluble fraction when grown in minimal medium)

incubated at room temperature for

1 hr,

then centrifuged at

10,000 rpm for 20 min to recover the soluble portion.

The

supernatant was dialyzed (25,000 molecular weight cutoff,
MWCO, dialysis tubing, Spectrapore) against 4° C H2O for

days with H2O changes.

3

The dialysate was then centrifuged

to remove impurities and the supernatant was lyophilized to

recover the recombinant (CS5 (VPGIG)
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40)

3

or (CS5 (VPGIG)

20) 5.

4.3.5 Cloud Point Measurements

The lower critical solution temperature (LCST)

,

or

cloud point, was determined as a function of concentration
for both (CS5(VPGIG)2o)5 and (CSS (VPGIG)

protein solutions of

4,

8,

400 Ml of distilled H2O at

cuvettes

(l mm)

"C was prepared.

were filled with 300

temperature was scanned from 10
°C/hr.

-

and 16 mg of the protein in

12,
4

For each

^o) 3.

/xl

Quartz

of solution and

°C to 15 °C at a

rate of

6

Percent transmittance was measured at 300 nm.

4.3.6 Film Casting

Glass coverslips (12 mm)

(presoaked for 24 hr in

concentrated H2SO4 and repeatedly rinsed with distilled
were coated with (CS5 (VPGIG) 20)

5

or (CS5 (VPGIG)

40)

3

solutions in formamide or water by addition of 40
1

H2O)

from
iil

of a

mg/ml solution to the top surface of the coverslip

followed by spreading of the solution with the tip of a
pipet. Fibronectin films were cast from 100 jug/ml solutions
in distilled H2O; 20

/il

of solution was applied to a glass

cover slip and spread with the tip of a pipet. The

coverslips were then dried overnight at 55

°C in vacuo.

Coverslips were incubated in 0.5 ml sterile H2O at 37
2

°C for

hours to remove excess protein and again dried in vacuo at

55 °C for

2

hours.
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4.3.7 Stability of Protein Coatings

Tritiated (CSS (VPGIG) 20)

5

and (CSS (VPGIG)

on glass surfaces as described previously.

^o)

3

were cast

Phosphate

buffered saline (PBS, O.S ml) was added to 24 well culture
dishes containing coverslips coated with tritiated protein.
To determine the accumulation of protein in solution over
time,

10

/ul

aliquots of PBS were removed at

30

min intervals

and transferred to scintillation vials containing

scintillation counting fluid.
triplicate.

4

ml of

Each coating was analyzed in

To determine the amount of protein removed with

repetitive washing, O.S ml aliquots of PBS were transferred
from the wells to scintillation vials at 30 min intervals.

Fresh PBS was added to the wells.
over a period of
triplicate.

3

These steps were repeated

hours and each surface was analyzed in

After three hours the glass coverslips were

removed from the wells, rinsed briefly with PBS and placed
in scintillation vials to determine the amount of protein

remaining on the surface.

Untreated glass surfaces were

used in each case as controls.

4.3.8 Cell Culturing and Morphology

Pooled primary HUVECs were cultured and maintained in
10 mm Falcon petri dishes.

HUVECs from passages 2-10, in

our hands, were used for all cell adhesion studies.

were washed with

5

Cells

ml phosphate buffered saline (PBS) once

and then harvested using Versine, a 0.02% EDTA solution in
PBS.

Harvested cells were resuspended in M199, serum free
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medium, counted using a hemocytometer and diluted to
a

density of

5

well dishes,

x lo' cells/ml.
5

x lo' cells/well,

glass coverslips.
for

4

HUVECs were transferred to 24

containing protein coated

Cells were maintained at 37 °c and 5% CO2

hours and fixed using 3.7

%

formaldehyde in PBS.

Briefly, glass coverslips containing attached cells were

removed from the culture well, washed three times with
phosphate buffered saline + CaCl2 (0.1 g/1) and MgCl, (0.1
g/1) (PBS+)

and placed in new 24 well plates. Cells were

fixed by addition of 0.5 ml 3.7
hr at

4

°C

%

formaldehyde in PBS for

followed by washing with distilled H2O.

1

Pictures

were taken of two different wells for each surface on a
phase contrast microscope.

Cell morphology was evaluated

from the photographs.

4.3.9 Competitive Inhibition

HUVECs were detached from 10 cm Falcon petri dishes and

counted as described above.

Cells were resuspended in M199

serum free medium at a concentration of

6

X

lO''

cells/ml.

GREDVDY (Research Genetics) peptide was added to the cell
suspension to achieve the following final concentrations:
0.0,

0.2,

0.4,

0.6,

0.8, and 1.0 mg peptide/ ml suspension.

The suspensions were incubated in a 37 °C water bath for 30

min followed by dilution to
the tissue culture wells.

and 5% CO2 for

4

x 10^ cells/ml and addition to

1

HUVECs were maintained at 37 °C

hours and observed and photographed under

the phase contrast microscope.
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4.3.10 Actin Filament Staining

HUVECs were harvested and counted as described
previously, diluted to
medium, and

x 10^ cells/ml in serum free M199

plated on coverslips coated with (CS5 (VPGIG) 20)

cast from formamide.
and 5% CO2 for
5

5

min with 3.7

4

%

Plated cells were incubated at 37 °C

hours, washed with PBS twice and fixed for

formaldehyde (from paraformaldehyde) in

The cells were again washed twice with PBS and fixed

PBS.

and permeabilized in PBS with 0.5% Triton x-100 and 3.7%

formaldehyde for

5

min at

0

Cells were then washed

°C.

several times with PBS and incubated for 10 min with PBS +
0.2

%

BSA.

Oregon Green™ conjugated phalloidin

(5 |xL,

Molecular Probes) was then added to each well with 500
PBS.

/LtL

Cells were incubated at 37 °C for 30 min and washed

well before mounting on microscope slides using Vecta
Shield.

Cells were visualized with a confocal microscope.

4.4 Results and Discussion

Proteins composed of repeats of the pentapeptide

-VPGVG- exhibit a LCST at approximately

Urry and Long.^^

Urry at al

.

25

°C as

shown by

went on to show that the

temperature at which the phase transition occurs can be
altered by varying the residue at the fourth position

(X)

the -VPGXG- pentapeptide; inclusion of a more hydrophobic

residue reduces the LCST while a more hydrophilic residue
raises the transition temperature. ^° Figure 4.1 shows the

LCST behavior of (CS5 (VPGIG) 20)

5

90

and (CS5 (VPGIG)

40)

3

in

40 mg/ml aqueous solutions.

of Urry et al

.

,

Consistent with the predictions

we find that the inclusion of the more

hydrophobic isoleucine residue reduces the transition
temperatures to 12.1 and 13.4

°C

respectively for the two

polymers as measured by cloud point analysis on
solutions as described above.

mg/ml

40

However, Urry et al

.

predict

that the transition temperature of the proteins should be

reduced to 10

°C.^°

Our slightly greater values may be due

to the incorporation of the CSS domain within the proteins.
On the other hand, the LOST of (CS5 (VPGIG)

higher than (CS5 (VPGIG) 20)

5

40)

3

is 1.3 °C

while the former has pentapeptide

blocks 200 amino acids long as compared to 100 amino acids
in the latter.

This argument would indicate that the LOST

of the pentapeptide (VPGIG)

13.4 °C.

itself would be greater than

This contradictioncan only be resolved when the

cloud point data of the polypentapeptide becomes available.

Retention of the LCST may be consistent with retention of
the elastomeric nature of the proteins.

Despite the existence of an LCST below body
temperature, small quantities of the material are soluble in

aqueous solution at 37

°C;

the two phase system is composed

of a protein rich phase and a protein poor, but not protein
free, phase.

To determine if sufficient protein remains on

glass surfaces for full coverage after addition of the

aqueous cell culturing medium, glass coverslips were coated

with tritiated protein and soaked in PBS as described.
Figure 4.2 shows the accumulation of (CS5 (VPGIG) 20)

5/

cast

.

from formamide, in solution over a

hour time period.

3

The

majority of the protein is dissolved within the first hour
with very little protein being removed thereafter.

The

other three protein cast films behave in a similar manner
(data not shown)

Table

4

.

1

shows the amount of protein removed over a

three hour period for both the case where the coverslips are

soaked in 0.5 ml PBS for

3

hours and when the PBS is removed

every

30

PBS.

Also shown is the amount of protein remaining on the

minutes and replaced with 0.5 ml aliquots of fresh

glass coverslips at three hours.
(CS5(VPGIG)4o)3 and approximately

In all cases 2-3
1

/xg

of

(CSS (VPGIG)

found on the coverslips after thorough washing.

discrepancy of 8-10

fiq

jixg

20)

of
5

were

There is a

of protein being cast and protein

being detected in all cases.

Although experimental error

can account for some of this discrepancy, there is still

several unaccounted

j^tg.

Since much of the protein goes into

solution within the first several minutes, there is a

protein solution in contact with the polystyrene tissue
culture well for

3

hours.

Protein is likely to have adhered

to the polystyrene well, which has a surface area

3

times

that of the coverslip.
Cast films were presoaked for

2

hours to remove the

excess protein prior to addition of the cells in serum free
medium.

Table 3.2 reports the number of cells adhered to the
cast surfaces of the two artificial extracellular matrix
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proteins, glass and fibronectin.

We found that essentially

all cells cast on fibronectin and on (CSS (VPGIG)

20)

were

5

adherent, while only about 25% of the cells cast on glass

and (CS(VPGIG)4o)3 were adherent.

We attribute the decrease

in the number of cells bound to (CS5 (VPGIG)

to (CSS (VPGIG)

20) 5

40)

3

as compared

to the lower CSS density in the former,

and possibly to a difference in protein conformation upon

adsorption to the glass surface which may present the REDV
sequence in a less than optimal manner.

Table 4.2 tabulates

the cell morphologies when attached to these surfaces.

Refractile cells are seen to be round and bright under the
phase contrast microscope, cells which were round but not

highly refractile were classified as round and grey,
spreading cells exhibited 1-2 pseudopodia, while spread
cells had >2 pseudopodia.

Not only did the glass surface

support far fewer cells than (CSS (VPGIG) 20) 5/ but half of the
cells on glass are highly refractile.
(CSS (VPGIG)

40)

3

40)

3

20)

5

< 20% of

the HUVECs on

are highly refractile; in this case half the

cells are well spread.
(CSS (VPGIG)

although

supports approximately the same number of

adherent cells as does glass,
(CSS (VPGIG)

In contrast,

The morphology of the cells on

is similar to that on (CSS (VPGIG)

however, the number of attached cells is

4

40)

3/*

times as great.

Although the data are not shown in table 4.2, all cells
plated on fibronectin are well spread after
free medium.
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4

hours in serum

5

Hubbell and colleagues have observed HUVEC
spreading on
glycophase glass which has been modified through
N-terminal
grafting of GREDVY peptides to the surface at a

concentration of approximately 10 pmol/cm'J'

As determined

from protein stability results 19

± 2

present on the glass coverslips.

Assuming that HUVECs have

pmol/cm^ of CSS are

access to the top 10 A of the recombinant protein film,
there is 10

± 2 pmol/cm^ of CSS

ligand available for

adhesion (compare to 10 pmol/cm^)

."^

They report the

percentage of attached cells that are spread to be 89

%.

Defining all nonref ractile cells as spread or spreading, we
find that -80
(CSS (VPGIG)

%

40)3

of attached cells are spread on both

and (CSS (VPGIG)

20) 5,

which is consistent with

results obtained by Hubbell and colleagues with similar
ligand densities.

Although the percent of well spread

HUVECs on fibronectin is higher than that on (CSS (VPGIG) 20)
cast from either water or formamide, upon addition of

complete medium containing

2

serum all of the HUVECs on

%

the artificial extracellular matrix protein become well

spread within an hour.
the (CSS (VPGIG) 20)

5

Both the fibronectin surfaces and

surfaces go on to become confluent in 36-

48 hours.

Figures 3.4a-3.4e show HUVECs on glass (3.4a),
(CSS (VPGIG)
(3.4b,

20)

3.4c)

5

cast from formamide and water respectively

and (CSS (VPGIG)

water (3.4d, 3.4e).

40)

3

cast from formamide and

The differences in cell numbers and

cell morphology can be seen clearly.

Figure 4.3a-b shows

confluent monolayers of HUVECs on fibronectin and on
(CS5(VPGIG)2o)5 respectively.

In both cases the expected

cobblestone morphology is observed.
Preliminary measurements of competitive inhibition of
EC attachment by soluble CS5 analogues have also been made.

As expected, pre-incubation of HUVECs with the soluble

peptide GREDVDY (Research Genetics, Inc.) at concentrations
up to

2

mg/ml has no observable effect on attachment to

fibronectin.

In contrast, attachment to (CSS (VPGIG)

20)

5

is

completely inhibited by GREDVDY at concentrations of 0.6-0.8
mg/ml.

Although this result is consistent with specific

attachment of HUVECs to CSS via the

a^^^

receptor, we have

not yet conducted controls with sequence-scrambled analogues
of the inhibitory peptide.

Figure 4.4 shows actin filament staining of

spread on (CSS (VPGIG) 20)
phalloidin.

i,

a

HUVEC

using Oregon Green conjugated

Actin filaments (Figure 4.4a) can be seen

clearly on the periphery of the cell, in addition, some
filaments can be seen (Figure 4.4b) that originate from near
the center of the cell and reach out toward the periphery.

Upon adhesion and spreading, many cells form actin filaments
or stress fibers.

These filaments play a role in the

anchorage and movement of membrane proteins and in the
locomotion of cells. ^°
including

ol^^i/^

In addition, many integrins,

bind both actin filaments and extracellular

matrix proteins and thereby serve as

a link

interior and the exterior of the cells.

between the

4.5 Conclusions

Both (CS5(VPGIG)2o)5 and (CSS (VPGIG) 40)
and spreading of HUVECs.

3

support adhesion

The presence of actin filaments as

seen in the Oregon Green™ conjugated phalloidin confocal
images of HUVECs spread on (CS5 (VPGIG)

20)

5

(Figures 5a

&

b)

is suggestive of a well organized cytoskeleton.

Morphological data shown in Table 4.2 suggests that more
than

7 0%

of the adherent cells are spread, and the number of

cells bound to (CS5 (VPGIG) 20)
on fibronectin (Table 3.2).

spread on (CS5 (VPGIG)
(CS5 (VPGIG)

20)

5

40)

3

5

is similar to the number bound

The morphology of the cells

is similar to that of cells on

as shown in Table 4.2.

This equivalencce

suggests that by changing the density of ligand we can
control the number of cells that attach to a material

without affecting the extent of individual cell spreading.
In addition, as seen in Figure 4.3 b,

(CS5 (VPGIG)

20) 5

supports HUVEC monolayer formation subsequent to the

addition of serum, which is necessary for optimal vascular
regeneration.

Competitive inhibition data suggests that the HUVECs
are binding to the artificial extracellular matrix proteins

through the CS5 region.

Preincubation with soluble GREDVDY

has no effect on HUVECs' ability to adhere to fibronectin,

indicating that the peptide is not inhibiting adhesion to
all surfaces.

In contrast, as the concentration of GREDVDY

peptide with which the HUVECs are incubated increases, the
number of cells that adhere to the artificial extracellular

matrix proteins decreases.

The soluble peptide inhibits

cell adhesion by blocking the

04^1

to the receptor in solution.

The receptor is then unable to

integrin through binding

bind to the CS5 domain of the proteins.

This inference

also suggests that the pentapeptide repeat does not support
cell adhesion, as blocking of adhesion to the REDV sequence

contained within the CS5 block inhibits cellular adhesion.
This conclusion will only be confirmed when synthesis of the

pentapeptide alone is complete and HUVEC adhesion to this

material can be tested.

Further evidence of adhesion

through the CSS domain is the increase in number of cells
adhered to (CS5 (VPGIG) 20)

5

as compared to (CSS (VPGIG)

40) 3/

the

latter having a S0% decrease in ligand density.

These materials also retain some of the characteristics
of the elastin portion of the proteins as suggested by the

observation of the LCST.

Both of the recombinant proteins

exhibit an LCST despite the fact that the elastin segments
are interrupted by the CSS region.

Despite the occurrence

of the LCST near 13 °C for both materials, they are water-

soluble in low concentrations at 37

°C;

however, complete

coverage of the glass coverslips after incubation in aqueous

medium for two hours was confirmed by SEM (data shown in
Appendix

D)

and scintillation counting.

We have synthesized artificial extracellular matrix

proteins which contain specific cell binding domains as well
as structural blocks that are expected to mimic native

elastin.

Control of the density of adhesion ligand controls
97

the number of cells adherent to the materials.

In addition,

preliminary work by Kathy DiZio in our laboratory suggests
that there is little or no smooth muscle cell adhesion to
(CS5 (VPGIG)2o)

5f

consistent with the work of Hubbell et al

using GREDVY grafted to glass surfaces.
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Table 4.1 Determination of Protein Stability on
Glass Covers lips

0.5 ml PBS for

hrs

3

polymer/
casting
solvent

accumulation
in solution

(CS5(VPGIG)2o)5

29.2

±

0.7

2.0

±

30.9

±

1.3

0.8

±

24.4

±

26.1

±

remaining on
coverslip

0.5 ml PBS exchanged
every 30 min

total
solubilized
Mg

remaining on
coverslip

0.6

32.6

±

2.9

0.6

±

0.2

0.3

30.3

±

1.9

0.5

±

0.1

4.9

3.2 ± 1.2

23.5

±

2.5

3.6

±

0.6

1.4

1.9

0.4

28.5

±

1.3

1.2 ± 0.5

Formamide
(CS5(VPGIG)2o),

Water
(CS5(VPGIG),o)j

Formamide
(CS5(VPGIG),„)

,

±

Water
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Table 4.2

HUVEC Morphology on Glass and Protein
Cast Surfaces.

Protein/
Cast From

Ref ractile

Round/Gray

%

Spreading

%

Spread

%

%

Glass

49.5

±

8.6

12.0

±

0.4

13.4

±

2.3

25.1

(CS5(VPGIG)2o)5
Fortnamide

15.2

±

5.9

14.6

±

3.4

14.4

±

5.0

55.8 ± 3.9

(CS5(VPGIG)2o)5

20.9

±

5.3

11.4

±

4.9

11.6

±

1.4

55.8

±

9.3

21.3 ± 2.5

48.7

±

2.2

4.0

53.7

±

6.6

±

7,8

Water
(CS5(VPGIG)4o)3

14.1 ± 1.2

15.9 ± 5.9

Formamide
(CS5(VPGIG)4o)3

18.7

±

7.2

16.3

±

Water

Spreading = 1-2 pseudopod
Spread =

> 2

pseudopod
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5.5

7.9

±

.

TEMPERATURE

C

Figure 4.1. LCST data of (CS5 (VPGIG) 20)
in aqueous solution (40 mg/ml)
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5

and (CSS (VPGIG)

^o) 3

V

0

25

50

75

100

125

150

175

Time (min)

- Glycine labeled
Accumulation of
(CSS (VPGIG) 2o) 5 in solution over 3 hours.
Films were cast
from formamide (total protein cast 40 /xg) and soaked in PBS
The majority of the solubilization
at 37 °C for 3 hrs.
occurs within the first hour.

Figure 4.2.
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b.

Figure 4.3. Confluent layers of endothelial cells are
supported by both fibronectin coated glass surfaces (4.3a)
and (CSS (VPGIG) 20) 5 coated glass surfaces (4.3b).
In both
cases the expected cobblestone morphology is seen.
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.

HUVECs which are allowed to adhere to
(CS5 (VPGIG) 20) 5 for 4 hours in serum free medium are spread.
Oregon Green^^ conjugated phalloidin was used to visualize
actin filaments which can be seen at the periphery of the
cell (4.4a) and extending from the center of the cell to the
periphery (4 4b)

Figure 4.4.

.
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CHAPTER

5

CONCLUSIONS AND FUTURE PERSPECTIVES

Recombinant extracellular matrix proteins have been

successfully synthesized as shown by SDS-PAGE, NMR
spectroscopy and amino acid analysis.
(CS5(VPGIG)4o)

3

(CS5 (VPGIG)

20) 5

and

were designed with the intent that the

pentapeptide repeat (VPGIG) 20,40 would provide the structural
integrity of the

material^^'^^'®^

while the CSS block would be

the ligand for HUVEC binding through the

oc^^^^^'^^'^^

integrin

receptor.

Both recombinant artificial extracellular matrix

proteins support the adhesion of HUVECs.

Competitive

inhibition studies with soluble GREDVDY suggest that the CSS

region is indeed the ligand for HUVEC adhesion to the
artificial extracellular matrix proteins.
Further support for the supposition that HUVECs are

binding primarily through the CSS domain of the polypeptides
comes from data showing that significantly fewer HUVECs bind
to (CSS (VPGIG)

40)

3

than bind to (CSS (VPGIG)

20) s-

The former

contains S0% fewer CSS blocks per pentapeptide repeat.

Thus

lower HUVEC adhesion to the former is consistent with

binding to the CSS block.

This trend again suggests that

the pentapeptide repeat does not promote cell adhesion.
The relationship between the density of the adhesion
ligand and the number of HUVECs which bind to the material

indicate that it is possible to control the initial cell
lOS

seeding density of a material.

This control will be

important in materials which are used for co-culture.

For

example, liver is a highly vascular material which contains

several different cell types among which are hepatocytes and

endothelial cells.

Hepatocytes are immediately juxtaposed

to the endothelial cells.

In this way, no cell is further

than two cells away from the bloodstream.

There is ready

and rapid diffusion of metabolites to all cells.

In order

to seed both cell types onto a matrix it will be necessary
to control the location and number of each type of cell to
be seeded.

This need is addressed with materials such as

these, since we can control precisely the type and density
of cell binding domains.

Both control of the binding ligand and control of the

structural integrity were designed into the materials.

The

elastin-based pentapeptide (VPGIG) was incorporated to

provide integral structural and elastomer ic integrity.

Although complete characterization of the mechanical
properties has not yet been achieved, we have demonstrated
that the materials maintain an LCST, which is inherent to

polymers based on multiple repeats of (VPGIG)

.

Urry has

suggested that it is the 3-turn conformation adopted by the

proteins upon phase separation that provides the entropic
basis for the elastomer ic properties of the proteins.®^
Thus, the observation of the LCST in our materials may

suggest retention of the 3-turn conformation in the protein
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rich phase of the biphasic system and favorable elastic
properties.

The surface stability studies show that the materials
are not insoluble in aqueous solution at 37 °C despite the

sub-ambient LCST.

In order to produce an insoluble material

it may be necessary to crosslink the protein.

Urry et al

have crosslinked similar proteins by Y-irradiation^\- this
is not ideal for cross linking these artificial extracellular

matrix proteins because the location of radical formation,
and hence of crosslinking, cannot be controlled.

Other

available options are crosslinking by glutaraldehyde or
The absence of lysine residues preempts the

formaldehyde.^^

methods.

Carbodiimide would cause crosslinking of the

glutamic and aspartic acid residues of the binding region

with amines.

Thus it appears that the traditional

crosslinking methods are accordingly less than ideal.

A novel crosslinking option might come from the
incorporation of an unnatural alkyne derivative of
isoleucine.

It has been shown in our laboratory that an

isoleucine derivative containing a terminal alkyne can be

incorporated into artificial proteins biosynthetically (vide
infra)

.

This alkyne derivative is apparently bound by the

isoleucyl tRNA synthetase and utilized to charge the
isoleucyl tRNA.

Even low levels of isoleucine replacement

by the unatural alkyne derivative would allow sufficient

crosslinking of these residues through alkyne chemistry.
The crosslink density and the mechanical properties of the
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material could then be altered by varying the
incorporation
of the alkyne derivative.

The incorporation of the alkyne would also allow for

crosslinking with other materials. The muscular arteries are

generally the arteries of interest for the design of small
diameter prostheses, for it is these arteries that fail and
are not readily repaired by current methods.^
in chapter

1,

As discussed

the arteries are composed of three tunicas.

It will be possible to blend the elastin-like proteins with

collagen analogues to mimic both the tunica media and the
adventitia.

Multilayered vascular grafts can be fabricated,

with crosslinking between and within the tunicas, to produce
vascular prostheses.

The fabricated vascular grafts can

then be seeded with endothelial cells and smooth muscle
cells.

These cells would be expected to remodel or rebuild

the extracellular matrix to produce a "natural" vessel.

An advantage of artificial extracellular matrix
proteins which have been designed through recombinant DNA

technology is that the proteins can be designed to contain
only specific signals.

Fibronectin itself contains fibrin,

heparin, collagen, DNA, and cell binding domains.^''

It is

not beneficial to have all of these binding domains exposed
to the blood stream.

thrombus formation.

Fibrin is involved in clotting and

Readily available binding sites for

fibrin may promote the binding of fibrin followed by the

formation of thrombi.

Recombinant DNA technology allows for

the isolation of function by the isolation of domains of a
108

protein.

As we have shown, it is possible to clone the CS5

region of fibronectin thus isolating only the ability to
bind to the

a^Pi

integrin receptor*

As demonstrated by the adhesion of recombinant
(CS5(VPGIG)2o)5 and (CS5(VPGIG)4o)3 to PTFE (see Appendix E)

,

these novel extracellular matrix materials can be used not
only as new graft materials, but to try to improve the

characteristics of currently available materials while new

materials are being developed.

It is also important to note

that just as biology is not limited to incorporating one
signal into a molecule, we are not limited to one signal per
molecule.

Through recombinant DNA techniques multiple

signals can be built into each molecule, whether they be
cell adhesion signals, molecular adhesion signals, or

protease degradation sites.

Moreover, we are able to design

out these same signals and so devise materials for use where

the presence of any of these signals would be undesirable.
We can make materials that are less prone to degradation by

endoproteases.

The current materials are the building

blocks for artificial extracellular matrices.
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APPENDIX A

GENETIC MAPS AND MANIPULATIONS

All DNA was synthesized on a

1

/xmol

scale on a

Biosearch Model 8700 DNA synthesizer using phosphoramidite

chemistry/^ As described in chapter

3,

all oligonucleotides

were purified, annealed and ligated into pUC18^% a cloning

vector which is depicted in Figure A.l, with the exception
of 28ap which was directly ligated into pET-28a (Figure
A. 2) and pEC2-link which was ligated directly into pEC2

transfer vector, pEC2 (Figure A.
(VPGIG)x into the Ban

I

3)

The

.

was used for inserting

site of the CSS and HBD regions and

for amplifying CS5(VPGIG)^ and HBD(VPGIG)y prior to ligation

into pET-28ap, the expression vector.

pET-28ap (Figure A. 4) was created by insertion of a new

cloning linker between the Nco

I

polycloning region in pET-28a.

and Xho

I

sites in the

As seen in Figure A.

5,

the

new cloning region consists of a start codon encoded in the
Nco

I

site, a cloning site encoding an Xho

I

restriction

site and two stop codons immediately following the cloning
site.

This allows for the expression of the artificial

extracellular matrix proteins without long fusions which

would need to be removed after synthesis.
Figures A.

5,

A. 6,

A. 7,

A. 8 and A. 9 show full

restriction maps of the DNA encoding 28ap, CS5,
HBD, pEC2-link respectively as synthesized.
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(VPGIG)5,

pEC2-link was

cloned directly into the Eco RI and Eag
sequenced.
into the Ban

I

sites of pEC2 and

It was designed to allow cloning of (VPGIG)^
I

site and then transfer of the DNA into pET-

28ap for expression without long fusions.

DNA manipulations are described in more detail in

experimental sections pertaining to gene construction and

protein expression in Chapter

3

Ill

and Appendix B.
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Figure A.l The pUC18 cloning vector. The cloning vector is
shown with the DNA sequence of the polycloning region
depicted below the plasmid. Synthetic DNA was ligated
between the Bam HI and Eco RI site of the cloning region.
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APPENDIX B
(HBD(VPGIG)2o)4 DESIGN AND SYNTHESIS

B.l Introduction

Extracellular matrix proteins contain multiple signals

which are encoded in the primary and possibly secondary and
tertiary structures of the molecule.

Fibronectin contains

several integrin binding domains, "'"^'^""^^ as well as heparin
and collagen binding domains. ^"'^^ Laminin, a second

extracellular matrix protein, also contains integrin and

heparin binding domains. ^^'^^

Furcht and colleagues have

found a peptide sequence in porcine laminin

(RYWLPRPVCFEKGMNYTVR) which binds heparan sulfate.
Cells have heparin sulfate proteoglycans on their

surfaces that can bind to the heparin binding domain (HBD)
It has been demonstrated that a combination of cell binding

domains and HBD induces focal adhesion contact formation, a

more permanent anchoring where the cytoskeleton fibrils
appear to be connected through cell membrane receptors to
the extracellular matrix, in

f ibroblasts^°°.

The inclusion of the heparin binding domain may aid in
the formation of more permanent adhesions to the artificial

extracellular matrix materials.

In addition,

it has been

shown that heparin inhibits the proliferation of smooth

muscle cells.

It will be possible to bind heparin to the

artificial extracellular matrix proteins that include
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heparin binding domains to inhibit the proliferation of
smooth muscle cells.

B.2 Experimental Methods

B.2.1 Preparation of Synthetic DNA

Oligonucleotides (Figure A. 8) were synthesized on

a

1

Hmol scale on a Biosearch Model 8700 DNA synthesizer using

phosphoramidite chemistry^®.

Crude oligonucleotides were

purified by denaturing polyacrylamide gel electrophoresis
and eluted using the "crush and soak" method^\

oligonucleotides were annealed at 80

°C

to room temperature over several hours.

Purified

and allowed to cool

The annealed HBD

duplex (Figure A. 8) was phosphorylated with T4

polynucleotide kinase, ethanol precipitated and dried in
vacuo

B.2.

2

.

Cloning and Amplification of Synthetic DNA

Purified HBD was ligated into Eco RI/Bam HI digested
pUC18 and used to transform E. coli strain DH5aF'.

Cells

were grown at 37 °C overnight on 2xYT solid medium

containing 200

/iig/ml

ampicillin, 25 /xg/ml 3-

isopropylthiogalactoside (IPTG) and

40

/xg/ml of the

chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-Dgalactopyranoside (X-Gal) for blue-white screening.

Plasmid

DNA from white transf ormants was sequenced using Sequenase
the
2.0 (Amersham Life Sciences) to verify the identity of
122

insert.

After isolation of the recombinant plasmid from a

15 ml 2XYT culture the HBD DNA was digested with Eco RI/Bam

HI and the fragments were separated by nondenaturing

polyacrylamide gel electrophoresis.

The DNA monomer was

eluted from the polyacrylamide slice using the "crush and
soak" method".

B.2.3 Cloning of HBD in Transfer Vector

Purified HBD monomer was ligated into Bam HI/ Eco RI

digested pEC2 plasmid DNA (the resultant plasmid was

designated pEC2-HBD)
DH5aF'.

,

and used to transform E. coli strain

Cells were grown overnight on 2xYT solid medium

containing 34

/xg/ml kanamycin.

Plasmid DNA from single

colonies was verified for HBD insert by Bam HI/Eco RI

digestion followed by

1

%

agarose gel electrophoresis and

staining with ethidiumbromide (EtBr)

;

bands of 101 bp

indicate proper ligation.

B.2.4 Polymerization of the (VPGIG)5 Monomer and Cloning of
(VPGIG)5 Multimers

Purified monomeric (VPGIG)5 DNA was self-ligated with
T4 DNA ligase to form a population of multimers.

were ligated into Ban

I

Multimers

digested, dephosphorylated pEC2-HBD.

The recombinant plasmids were used to transform E. coli

strain DHSaF'.

Transf ormants were screened by PCR^^ with

cycling times and temperatures as follows: 96
°C,

2

min; 72°C,

2

min with 35 cycles.
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°C,

1

min; 45

Vent polymerase was

used with Pst
Biolabs)

I

site primers for pBR322 (New England

Amplified DNA was visualized with EtBr following

.

separation by 1% agarose gel electrophoresis.

encoding

4

A clone

repeats of the (VPGIG)5 monomer was chosen.

The

recombinant plasmid was designated pEC2-HBD (VPGIG) 20.

B.2.5 Construction of Bacterial Expression Vector

Recombinant pEC2-HBD (VPGIG) 20
I /Sal

I

was digested with Xho

to release the HBD- (VPGIG) 20 DNA cassette.

The

cassette was separated by 1% agarose gel electrophoresis and

recovered by extraction with Qiaex II DNA extraction kit
(Qiagen)

.

The recovered DNA was ligated into Xho

digested, dephosphorylated

I

pET-28ap (the resulting plasmid

was designated pET-28ap (HBD (VPGIG) 20) x where x designates the

number of cassettes which have been ligated)

,

and used to

Transf ormants were

transform E, coli strain DH5aF'.

screened for the presence and orientation of each multimer
by Pflm I/Xho

I

digestion.

This process was performed

repeatedly (Figure B.l) to obtain a recombinant plasmid,

designated pET-28ap (HBD (VPGIG) 20)

transform the expression host,

4 /

which was used to
coli strain

E.

BL21 (DE3)pLysS.

B.2.6 Protein Expression, Batch Phase, Rich Medium
Single colonies of BL21 (DE3 pLysS containing
)

recombinant pET-28ap (HBD (VPGIG) 20)

4

were used to inoculate

5

ml of 2xYT medium containing chloramphenicol (34 ^iq/ml) and
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kanamycin (34 ^g/ml)

The cultures were grown to saturation

.

and a 50 nl aliquot was used to inoculate fresh

5

ml volumes

of 2xYT medium containing chloramphenicol (34 /xg/ml) and

kanamycin (34

/ig/ml)

The cultures were grown to

.

OD.no =

1

at 37 °C and protein expression was induced by the addition
of IPTG to a final concentration of 1.0 mM.

taken at

t = 0,

1,

2

units per 10

/liI

centrifuged at 14,000 x g and

hr,

resuspended in distilled

Samples were

H^O at a

concentration of 0.2

ODgoo

for analysis by SDS-PAGE.

B.3 Results and Discussion

Samples were loaded onto

a 10%

polyacrylamide gel and

separated by electrophoresis under denaturing conditions.

Protein bands were stained with Coomassie Brilliant Blue RFigure B.2 is

250.

a

10% polyacrylamide gel containing

whole cell lysate samples of BL21 (DE3 pLysS pET-28ap)

(HBD (VPGIG)

po)

Lane

^ •

1

contains molecular weight standards

while lanes 2-4 contain whole cell lysates from cultures of
colony

latt=0, t=lhr, t=2hr

respectively.

Lanes

5-7, 8-10, and 11-14 contain whole cell lysate from colonies
In no case can a band be seen which

2-4 respectively.

corresponds to recombinant protein (expected molecular

weight near 46 Kda)

.

The lack of protein expression may be attributed to the

choice of codon usage at the start of the recombinant DNA.
The (CSS (VPGIG) 2o)
(HBD(VPGIG)2o)

4

5

construct is very similar to the

construct.

The differences are limited to
125

the cell binding domains.

Since the encoded DNA and mRNA

messages begin with the binding domains it is likely that
the expression problem lies within HBD.

This must be

confirmed by sequencing the synthetic gene in the expression
vector to be sure that no base pair deletions or additions
have occurred during genetic manipulations which may cause
lack of expression.
of

If no genetic defects exist copolymers

(CS5(VPGIG)^HBD(VPGIG)y) can be constructed.

In this

case the CSS domain will be at the start of the gene and may
thus allow expression of the HBD.
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Figure B.2 A 10% SDS-PAGE of an (HBD (VPGIG) 20)
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Lane 1 contains molecular weight standards
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Lanes 5-7, 8-10, and
respectively.
0
2-4
11-13 contain whole cell lysates from colonies
respectively at similar time points.
4

t=lhr,t=2hr
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APPENDIX C

DESIGN AND SYNTHESIS OF (VPGIG)x

C.l Experimental Methods

C.1.1 Preparation of Synthetic DNA

Oligonucleotides were synthesized on a

1

/Ltmol

scale on

a Biosearch Model 8700 DNA synthesizer using phosphoramidite

chemistry/®

Oligonucleotides were annealed at 80

°C

and

allowed to cool to room temperature over several hours.

The

annealed pEC2-link duplex (Figure A. 9) was phosphorylated
with T4 polynucleotide kinase, ethanol precipitated and

dried in vacuo.

C.1.2 Cloning and Amplification of Synthetic DNA

The pEC2-link duplex was ligated into Eco RI/Eag

I

digested pEC2 and used to transform E. coli strain DH5aF'.
Cells were grown at 37 °C overnight on 2xYT solid medium

containing 25

/ng/ml kanamycin.

Plasmid DNA from

transf ormants was sequenced using Sequenase 2.0 (Amersham
Life Sciences) to verify the identity of the insert.

C.1.3 Cloning and Amplification of (VPGIG)5

Purified (VPGIG)

5

DNA was ligated into Eco RI/Bam HI

digested pUC18 and used to transform E. coli strain DH5aF'.
Cells were grown at 37 °C overnight on 2xYT solid medium and
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sequenced as described in chapter

recombinant plasmid from a

3.

After isolation of the

liter 2xYT culture, the

1

(VPGIG)^ DNA was digested with Ban

I

and the fragments were

separated by nondenaturing polyacrylamide gel
electrophoresis.

DNA monomer was eluted from the

polyacrylamide slice, using the "crush and soak" method/^

C.1.4 Polymerization of the (VPGIG),, Monomer and Cloning of
(VPGIG)s Multimers

Purified monomeric (VPGIG)

r,

DNA was self-ligated with

T4 DNA ligase to form a population of multimers.

were ligated into Ban

I

Multimers

digested, dephosphorylated pEC2-

The recombinant plasmids were used to transform

link.

E. coli strain DH5aF'.

Transf ormants were screened by PGR

with cycling times and temperatures as follows: 96
min; 45 °C,

2

min; 72°C,

2

min with 35 cycles.

polymerase was used with Pst
England Biolabs)

.

I

"C,

1

Vent

site primers for pBR322 (New

Amplified DNA was visualized with EtBr

following separation by 1% agarose gel electrophoresis.
clone encoding 11 repeats of the (VPGIG)

VPGIG)

monomer was

The recombinant plasmid was designated pEC2-link-

chosen.
(

5

A

5,.

C.1.5 Construction of Bacterial Expression Vector

Recombinant pEC2-link- (VPGIG)
I/Sal

I

to release (VPGIG)

55.

55

was digested with Xho

The DNA was separated by 1%

agarose gel electrophoresis and recovered by extraction with
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Qiaex II DNA extraction kit (Qiagen)
ligated into Xho

I

The recovered DNA was

.

digested, dephosphorylated pET-28ap and

used to transform E. coli strain DH5aF'; the recombinant

plasmid was designated pET-28ap (VPGIG)

Transf ormants

55.

were screened for the presence and orientation of each

multimer by Pflm I/Xho

I

digestion.

DNA ligated in the

correct orientation was indicated by a DNA band of -12 50 bp
as visualized by

1

agarose gel electrophoresis followed by

%

staining with ethidiumbromide.

The expression host

BL21 (DE3) pLysS was transformed with pET-28ap (VPGIG)

55.

C.1.6 Protein Expression, Batch Phase, Rich Medium
Single colonies of BL21 (DE3 pLysS containing
)

recombinant pET-28ap (VPGIG)

55

were used to inoculate

2xYT medium containing chloramphenicol (34

kanamycin (34
and 50

ill

/iig/ml)

.

was used to inoculate fresh

.

ml of

and

The cultures were grown to saturation

medium containing chloramphenicol
(34 /xg/ml)

jtig/ml)

5

5

ml volumes of 2xYT

(34 /xg/ml)

The cultures were grown to

and kanamycin

ODgoo =

1

at 37 °C

and protein expression was induced by the addition of IPTG
to a final concentration of 1.0 mM.
2

hrs

1

Every 60 minutes for

ml samples were taken, centrifuged at 14,000 x g and

resuspended in distilled
units per 10

jul

H2O at a

concentration of 0.2

for analysis by SDS-PAGE.

ODgoo

However, SDS-PAGE

of whole cell lysate followed by staining with Coomassie

Briliant blue revealed no bands at 24,483 Da, the expected

molecular weight.

C.1.7 Protein Expression, ^H-Glycine, M9AA

A single colony of BL21 (DE3) pLysS containing

recombinant pET-28ap (VPGIG)

55

was used to inoculate

M9AA containing chloramphenicol
(34 /ig/xnl)

^iq /ml)

(34

5

ml of

and kanamycin

The culture was grown to saturation and used to

.

inoculate 25 ml of M9AA medium containing chloramphenicol
and kanamycin (34 ^q/ml)

(34 /xg/ml)

to

ODgoo = 0.8

.

The culture was grown

at 37 °C and protein expression was induced by

addition of IPTG to a final concentration of 1.0 mM; after

allowing T7 RNA polymerase to be produced, 34

^,q/ml

rifampicin was added to inhibit E. coli RNA polymerase; 10
minutes later 150

/Ltl

of

1

glycine was added for

/iCi//il

incorporation into the artificial protein.
for

2

hrs

1

Every 60 minutes

ml samples were taken, centrifuged at 14,000 x g

and resuspended in distilled H2O at a concentration of 0.2
ODeoo

units per 10

ill

for analysis by 10

%

SDS-PAGE.

Following SDS-PAGE, run at 16 mA through the stacking gel
and 30 mA through the resolving gel, the gel was stained

with Coomassie Brilliant Blue R-250, dried in vacuo and Xray
film was exposed to the gel for

2

showed a dark band appearing at

23

(data not shown)

.

days.

The developed film

Kd in the induced samples

Still no band could be seen on the

Coomassie stained radioactive gel indicating that the

recombinant protein does not stain with Coomassie Blue.

The

lack of staining of the gel makes it difficult to determine

the amount of expression prior to purification of the

recombinant protein.

APPENDIX D

SEM ANALYSIS OF PROTEIN COATING

Protein coatings were prepared as described in chapter
3.

Briefly, 40

fil

of 40 mg/ml solutions of protein were

spread on 12 mm glass coverslips.

The protein coated

coverslips were then dried in vacuo at 55

°C.

Coverslips

were imaged at this stage after coating with gold palladium.

Protein coated coverslips were incubated at 37 °C with
0.5 ml water to remove excess protein.

dried at 55 °C in vacuo.

They were once again

Coverslips were also imaged at

this stage.

Imaging and elemental analysis were both performed on

JEOL 6320-FXI field emission microscope.

a

The samples were

coated with gold/palladium by sputter coating, then imaged
Samples for elemental analysis were analyzed

at 10 kV.

uncoated at

5

kV.

Figures D.la

&

b show x-ray elemental analysis of the

glass coverslip (Fig. D.la) and glass coated with
(CSS (VPGIG)

protein.

20)5

(Fig. D.lb)

prior to removal of excess

A silicon peak is apparent on the uncoated

coverslip, but it is not seen on the protein coated

coverslip prior to soaking in PBS to remove excess protein.
On the protein coated coverslip profile there is also marked

suppression of the oxygen peak and loss of the sodium peak
while a carbon peak can clearly be seen.
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The protein

.

coating was thick enough that detection of the underlying
glass was not possible.

Once excess protein was removed,

the glass signals were visible even with the protein
coating, so this method could not be used to determine

protein coatings.

Determination of coating was then done by

scintillation counting as described in chapter
Figures D.2a
(CS5 (VPGIG)

20)

5

&

4.

b show SEM images obtained from

coated coverslips before excess protein was

removed (Fig D.2a) and after protein removal (Fig D.2b).
both cases the surface looks cracked and textured.

Glass

alone looks quite smooth with no cracks (data not shown)

These images coupled with the scintillation counting data
suggest complete coverage of the coverslips prior to cell
culturing.
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In

of P^^^ein coated glass
analysis
Elemental
D.l
Figure
with
co?erslips. A4 la is a glass coverslipand no C peak is seen
seen
prominent Si and Na peaks can
(VPGIG) 20} b/
Ka
i=
nlass coverslip coated with (CS5
and a C peak can clearly be
plakrhavrbeen'lost
Na
Si'and
seen.
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a

Figure D.2 SEM images of (CSS (VPGIG) 20) 5 coated coverslips.
of
A4.2a shows a protein coated coverslip prior to removal
coverslip
excess protein, while A4.2b shows a protein coated
coated
after removal of excess protein. Both samples are
with gold/palladium and imaged at 5 kV.
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APPENDIX E

HUVEC CULTURING ON PTFE COATED COVERSLIPS WITH
ARTIFICIAL
EXTRACELLULAR MATRIX PROTEIN COATINGS

E.l

Materials and Methods

E.1.1 PTFE Coating of Coverslips

Glass coverslips were coated with
102

p^pj,

a

thin layer of

Briefly, a hot plate was heated to 300 °C; a 12 mm

glass coverslip was placed on the hot plate and a piece of
PTFE was manually drawn across the coverslip
same direction.

4

times in the

PTFE coating was verified by SEM imaging of

gold/palladium coated coverslips.

Figure E.l shows an SEM

image; the PTFE is seen in the image as long peaks and

valleys

E.l.

Protein Coating of Coverslips

2

Coverslips were placed into the wells of a 24 well

culture dish and 0.5 ml of a 40 mg/ml protein solution was
added.

After incubation at

4

°C overnight,

the protein

solution was removed and the coverslips were dried at 55
in vacuo as described in chapter

E.l.

3

3.

Determination of Protein Stability
The determination of the stability of the protein on

the surface was done using ^H-glycine labeled protein
137

°C

coupled with scintillation counting as described in chapter
4.

The stability was determined only by the method in which

0.5 ml of PBS was added to each well for

hours during

3

which time small aliquots were taken at 30 minute intervals
to determine the amount of protein solubilized over time.

The amount of protein remaining on the coverslips was also

determined by scintillation counting as described in chapter
4

.

E.1.4 HUVEC Culturing
Cell culturing was done as described in chapter

Coverslips coated with PTFE
(CSS (VPGIG)

2o)

5

,

as well

and (CS5 (VPGIG)

in formamide and water,

trif luoroethanol

(TFE)

40)

3

PTFE adsorbed, with

sls

from solutions of protein

and as suspensions of protein in

were used for cell culturing.

were suspended in serum free M199 at
of suspension was added to each well.
at 37 °C and 5% CO: fo^

3.

4

10''

cells/ml and

HUVECs
1

ml

HUVECs were incubated

hours.

E.2 Results and Discussion

Table E.l shows the amount of protein removed after

3

hr incubation in PBS at 37 °C as well as the amount of

protein remaining on the PTFE coated coverslips after the
incubation period.

Approximately

1

of each protein

remains on the surface with the exception of (CS5 (VPGIG)

adsorbed from formamide, where more than
remained.

2

/xg

20) 5

of protein

This correlates to a protein thickness of ^20 A.
138

Only moderate improvement of cell adhesion was seen on
the protein coated PTFE surfaces as compared to the PTFE

surfaces alone.
A slight increase in the number of cells adhered to

artificial extracellular matrix treated coverslips was
observed by visualization by phase contrast microscopy.

Quantitative evaluation must be done to determine the
significance of the increase in cell adhesion.
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Table E.l Stability of Protein Coatings on
PTFE Coated Glass

Casting
Solvent

(CS5 (VPGIG)

Removed

Formamide

11.4

Water

12.6

TFE

19.0

±3.2
±4.2
±1.9

(CS5 (VPGIG)

20) %

Remaining

Removed
14.0

±2.9

1.0

1.4

15.0

1.5

0.7

±0.1

11.0

±1.9
±2.3

140

3

Remaining

±0.3
±0.1

2.4

40)

0.8

±0.1
±0.1
±0.1

Figure E.l SEM image of PTFE spread on glass. The PTFE
coated coverslip was coated with gold/palladium and imaged
The streaked appearance of the surface is due to
at 5 kV.
the PTFE.
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APPENDIX F
2-D NOSY NMR SPECTRUM of POLY (AG)

To determine whether there had been mutation in (AG) 240
a 2-D NOSY NMR spectrum was taken at 500 MHz.

shows the spectrum obtained.

Figure F.l

Cross peaks can clearly be

seen between putative valine methyl resonance at 1.1 ppm and

the Gly

C„

peak at 4.3 ppm as well as between the 1.1 ppm

peak and the Ala

Cp.

This information coupled with the

amino acid analysis data reported in chapter

there is valine present in the backbone of
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2

(AG)

indicate that
240-

PGLV AG
[M a2 FORMIC ACID
MOESY iSOflsec nixing time
5sec recycle tine

Dresaturate DCOOH proton

(Kl^rting

acQ ana

ftix

J

La

T

If

- 2

- A

- 6

l?0

ppm

I

'

|MMM.

IM.M..MJ.MM..M

4

2

,

ppm

8

6

..~.r ,5-r,«"r
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,;.r
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